: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

Abstract • About • The 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF

COVID-19

Free Subscription

Articles published in Int J Infect Dis
Retrieve available abstracts of 597 articles:
HTML format

Single Articles

November 2025

SILVA CAC, Bomfim AP, Medeiros JD, Silva JJ, et al
Nasal Microbiota and Clinical Features in Acute Flu-Like Illness: COVID-19 Status and Long COVID Follow-Up.
Int J Infect Dis. 2025 Nov 11:108196. doi: 10.1016/j.ijid.2025.108196.
PubMed Abstract available

SONG J, Jeong S, Chun AY, Jung J, et al
Incidence of Respiratory Infections after the COVID-19 Pandemic (2023-2024) and Its Association of Vaccination Among Entire Populations in Korea.
Int J Infect Dis. 2025 Nov 7:108194. doi: 10.1016/j.ijid.2025.108194.
PubMed Abstract available

VERGORI A, Matusali G, Lepri AC, Cimini E, et al
Supporting equitable booster strategies: one-year real-world immunogenicity data in people with HIV (PWH) receiving different variant-adapted COVID-19 vaccines.
Int J Infect Dis. 2025 Nov 7:108189. doi: 10.1016/j.ijid.2025.108189.
PubMed Abstract available

HONG Y, Zhu F, Chen Y, Liu Y, et al
Competitive Dynamics of ST764 and ST5 MRSA in a New Tertiary ICU: Enhanced Hospital Adaptation via agrC Mutations Post-COVID-19.
Int J Infect Dis. 2025 Nov 4:108186. doi: 10.1016/j.ijid.2025.108186.
PubMed Abstract available

October 2025

CREUS-COSTA A, Andres C, Vila J, Gonzalez-Sanchez A, et al
Decline in pediatric respiratory syncytial virus hospitalizations following nirsevimab implementation: a multicenter, three-season observational study.
Int J Infect Dis. 2025 Oct 31:108170. doi: 10.1016/j.ijid.2025.108170.
PubMed Abstract available

LAU JC, Cheung KW, Yu Q, Wu P, et al
Disease Pattern, Risk factors of Antimicrobial Resistance in Patients with Pneumococcal Infection in Hong Kong Population.
Int J Infect Dis. 2025 Oct 30:108174. doi: 10.1016/j.ijid.2025.108174.
PubMed Abstract available

ZHANG S, Yang M, Zhou W, Yao Y, et al
Changes of Dynamics of Influenza before and after COVID-19 Pandemic: A Global Study in Eight Regions.
Int J Infect Dis. 2025 Oct 29:108173. doi: 10.1016/j.ijid.2025.108173.
PubMed Abstract available

MARKING U, Wahlstrom E, Holm J, Walther S, et al
Risk factors for hospitalisation and death due to COVID-19 during endemic Omicron circulation, a population-based cohort study.
Int J Infect Dis. 2025 Oct 27:108156. doi: 10.1016/j.ijid.2025.108156.
PubMed Abstract available

DIAZ Y, Ortiz A, Weeden A, Castillo D, et al
Corrigendum to "SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama", [International Journal of Infectious Diseases, 108 (2021), 588-591, https://doi.org/10.1016/j.ijid.2021.06.004].
Int J Infect Dis. 2025;161:108124.
PubMed

CARVALHO-SAUER R, Costa MDCN, Flores-Ortiz R, Teixeira MG, et al
Case Fatality Rate and Determinants of Maternal Death among Pregnant Women with SARS-CoV-2 Infection: A Population-Based Cohort Study in Bahia, Brazil.
Int J Infect Dis. 2025 Oct 20:108144. doi: 10.1016/j.ijid.2025.108144.
PubMed Abstract available

OH J, Kim S, Jo H, Park J, et al
Burden of post-acute sequelae of COVID-19 in patients with type 2 diabetes: a binational cohort study in South Korea and Japan.
Int J Infect Dis. 2025 Oct 18:108143. doi: 10.1016/j.ijid.2025.108143.
PubMed Abstract available

DEB D, Heidari ME, Kizito B, Kesamang M, et al
HIV status is not associated with SARS-CoV-2 viral load and longer duration of infection among people with well-controlled HIV and high COVID-19 vaccine coverage.
Int J Infect Dis. 2025 Oct 17:108142. doi: 10.1016/j.ijid.2025.108142.
PubMed Abstract available

GENTILOTTI E, Gorska A, Tacconelli E
Research on post-COVID syndrome: current gaps and future perspectives.
Int J Infect Dis. 2025 Oct 16:108129. doi: 10.1016/j.ijid.2025.108129.
PubMed Abstract available

OPPONG AE, Coelewij L, Hutchinson M, Carpenter B, et al
Simple hyperinflammation scores predict mortality in hospitalised patients with COVID-19 and offer a personalised medicine approach to dexamethasone intervention.
Int J Infect Dis. 2025 Oct 13:108119. doi: 10.1016/j.ijid.2025.108119.
PubMed Abstract available

SONG JY, Choi WS, Heo JY, Kim YR, et al
Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, non-randomised extension of a phase 1/2 trial.
Int J Infect Dis. 2025 Oct 8:108108. doi: 10.1016/j.ijid.2025.108108.
PubMed Abstract available

LI Y, Sun C, Zhao T, Ni Y, et al
Etiology of Initial Treatment Failure in Non-immunosuppressed Adult Patients with Community-acquired Pneumonia.
Int J Infect Dis. 2025 Oct 8:108110. doi: 10.1016/j.ijid.2025.108110.
PubMed Abstract available

FARINAS RP, Alonso-Sardon M, Solis P, Alonso BR, et al
The impact of the SARS-CoV-2 pandemic on the development of respiratory infections caused by Aspergillus spp., Mucor spp., and Pneumocystis jirovecii within the National Health System of Spain.
Int J Infect Dis. 2025 Oct 7:108101. doi: 10.1016/j.ijid.2025.108101.
PubMed Abstract available

KIM JA, Park S, Cho H, Jeong NY, et al
Sex Differences in Adverse Event Reporting Rates Following COVID-19 Vaccination in South Korea During the Pandemic.
Int J Infect Dis. 2025 Oct 6:108107. doi: 10.1016/j.ijid.2025.108107.
PubMed Abstract available

WAN EYF, Choi MH, Wang B, Xu Y, et al
Comparative Effectiveness of Combination Therapy with Nirmatrelvir-Ritonavir and Molnupiravir versus Monotherapy with Molnupiravir or Nirmatrelvir-Ritonavir in Hospitalised COVID-19 Patients: A Target Trial Emulation Study.
Int J Infect Dis. 2025 Oct 3:108097. doi: 10.1016/j.ijid.2025.108097.
PubMed Abstract available

QASEM DMAA, Esawy DAS, Asiri DIAAZ, Alasiri MFM, et al
Case Report: Severe Neonatal Legionella pneumophila Pneumonia: Insights from Clinical Management and Epidemiological Investigation.
Int J Infect Dis. 2025 Oct 1:108098. doi: 10.1016/j.ijid.2025.108098.
PubMed Abstract available

PERROUD AP, Coronel DL, Rivas E
Analyzing Seasonal Trends of Respiratory Syncytial Virus Circulation Using Latin American National Surveillance Database during Pre- and Post-COVID-19 Pandemic.
Int J Infect Dis. 2025 Oct 1:108095. doi: 10.1016/j.ijid.2025.108095.
PubMed Abstract available

September 2025

KIM JM, Kim JA, Rhee JE, Kim EJ, et al
Genomic surveillance for community-acquired pneumonia of unknown etiology in children.
Int J Infect Dis. 2025 Sep 27:108093. doi: 10.1016/j.ijid.2025.108093.
PubMed Abstract available

BONGUILI NCB, Mombo IM, Lenguiya LH, Lattaphasavang V, et al
Etiology and Epidemiology of respiratory infections in community-based influenza-like illness during the COVID-19 pandemic, Vientiane, Lao People's Democratic Republic.
Int J Infect Dis. 2025 Sep 25:108079. doi: 10.1016/j.ijid.2025.108079.
PubMed Abstract available

TENG Z, Li L, Che T, Liang J, et al
A Novel Balamuthia Lineage Causing Fatal Granulomatous Amoebic Encephalitis in an Immunocompetent Infant.
Int J Infect Dis. 2025 Sep 17:108063. doi: 10.1016/j.ijid.2025.108063.
PubMed Abstract available

PASQUINI Z, Toschi A, Gibertoni D, Amicucci A, et al
Risk Factors for Persisting SARS-CoV-2 Infection in Patients with B-Cell Malignancies in the Omicron Era: A Multicenter Cohort Study.
Int J Infect Dis. 2025 Sep 8:108053. doi: 10.1016/j.ijid.2025.108053.
PubMed Abstract available

ROWE SL, Sullivan SG, Koerber JJ, Munoz FM, et al
Adverse events associated with COVID-19 vaccination or diagnosis among pregnant and non-pregnant women in the United States, 2021-2022.
Int J Infect Dis. 2025 Sep 5:108050. doi: 10.1016/j.ijid.2025.108050.
PubMed Abstract available

SAGHAUG CS, Markussen DL, Knoop ST, Holvik BC, et al
Diagnostic Accuracy of a Host Response Test in Suspected Community-Acquired Pneumonia During the COVID-19 Era.
Int J Infect Dis. 2025 Sep 2:108045. doi: 10.1016/j.ijid.2025.108045.
PubMed Abstract available

SIMONSEN L, Pedersen RK, Andreasen V, Krause TG, et al
A Disease Suppression Strategy in Action: The Impact of Non-Pharmaceutical interventions in the COVID-19 pandemic in Denmark.
Int J Infect Dis. 2025 Sep 2:108039. doi: 10.1016/j.ijid.2025.108039.
PubMed Abstract available

August 2025

SHANG L, Perniciaro S, Weinberger DM
Changes in pneumococcal deaths in the United States following the COVID-19 pandemic.
Int J Infect Dis. 2025 Aug 29:108020. doi: 10.1016/j.ijid.2025.108020.
PubMed Abstract available

FERNANDEZ-DE-LAS-PENAS C, Ruiz-Ruigomez M, Esparcia-Pinedo L, Colom-Fernandez B, et al
Classical Pathway Persistent Complement Activation is Associated with Specific Symptoms in Individuals with Post-COVID-19 Condition: A Case-Control Study.
Int J Infect Dis. 2025 Aug 28:108032. doi: 10.1016/j.ijid.2025.108032.
PubMed Abstract available

TENG O, Quek AML, Ooi DSQ, Wang S, et al
High CD4(+) T-cell Responses in Seronegative Individuals Following SARS-CoV-2 Exposure during a Dormitory Outbreak.
Int J Infect Dis. 2025 Aug 20:108024. doi: 10.1016/j.ijid.2025.108024.
PubMed Abstract available

TURJEMAN A, Drozdinsky G, Leibovici L
The Impact of the COVID-19 Pandemic on Influenza Vaccination: A Multi-Year Interrupted Time Series Analysis.
Int J Infect Dis. 2025 Aug 11:108015. doi: 10.1016/j.ijid.2025.108015.
PubMed Abstract available

CARAZO S, Ouakki M, Nicolakakis N, Falcone EL, et al
Long COVID risk and severity after COVID-19 infections and reinfections: a retrospective cohort study among healthcare workers.
Int J Infect Dis. 2025 Aug 7:108012. doi: 10.1016/j.ijid.2025.108012.
PubMed Abstract available

July 2025

DAVIDO B, Loubet P
The Silent Surge: The Underrecognized Burden of Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Viruses in Adults.
Int J Infect Dis. 2025 Jul 31:108006. doi: 10.1016/j.ijid.2025.108006.
PubMed Abstract available

MASI P, Lescroart M, Veinstein A, Desmedt L, et al
Antifungal Concentrations in Mechanically Ventilated COVID-19 Patients With or Without ECMO: The CAPADOSE observational retrospective multicenter Study.
Int J Infect Dis. 2025 Jul 25:107996. doi: 10.1016/j.ijid.2025.107996.
PubMed Abstract available

ZHANG Y, Guo J, Li Y, Song Y, et al
Pre-pregnancy vaccination with inactivated vaccines protects SARS-CoV-2-exposed neonates from respiratory distress.
Int J Infect Dis. 2025 Jul 16:107978. doi: 10.1016/j.ijid.2025.107978.
PubMed Abstract available

COBO-VAZQUEZ E, Aguilera-Alonso D, Grandioso-Vas D, Gamell A, et al
SHARP INCREASE IN THE INCIDENCE AND SEVERITY OF INVASIVE STREPTOCOCCUS PYOGENES INFECTIONS IN CHILDREN AFTER THE COVID-19 PANDEMIC (2019-2023): A NATIONWIDE MULTICENTER STUDY.
Int J Infect Dis. 2025 Jul 16:107982. doi: 10.1016/j.ijid.2025.107982.
PubMed Abstract available

SIEBNER AS, Griesbaum J, Huus KE, Flugge J, et al
Class switch towards IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccinees.
Int J Infect Dis. 2025 Jul 16:107990. doi: 10.1016/j.ijid.2025.107990.
PubMed Abstract available

JIA Y, Zhang L, Xie Y, Hao L, et al
Incidence of acute respiratory infections and their associated pathogen distribution among residents in Shanghai, China: Preliminary results from community-based surveillance in the 2023-24 influenza season.
Int J Infect Dis. 2025 Jul 3:107974. doi: 10.1016/j.ijid.2025.107974.
PubMed Abstract available

BERG J, Linden K, Zaigham M, Domellof M, et al
The Association between Antenatal SARS-CoV-2 Exposure and Infant Neurodevelopment at Four Months of Age: A Prospective Multicenter Cohort Survey within the COPE Study.
Int J Infect Dis. 2025 Jul 3:107973. doi: 10.1016/j.ijid.2025.107973.
PubMed Abstract available

June 2025

ZHANG X, You Y, Liu J, Sun L, et al
Effect of COVID-19 non-pharmaceutical interventions on the epidemic trends of scarlet fever in China: A population-based surveillance and modeling study.
Int J Infect Dis. 2025 Jun 27:107969. doi: 10.1016/j.ijid.2025.107969.
PubMed Abstract available

CHAPMAN A, Barouch DH, Lip GYH, Pliakas T, et al
Risk of severe outcomes from COVID-19 in comorbid populations in the Omicron era: a systematic review and meta-analysis.
Int J Infect Dis. 2025 Jun 24:107958. doi: 10.1016/j.ijid.2025.107958.
PubMed Abstract available

PAUL E, Brown GW, Dechamps M, Kalk A, et al
Corrigendum to "COVID-19: an 'extraterrestrial' disease?", [International Journal of Infectious Diseases, Volume 110, 155-159, September 2021].
Int J Infect Dis. 2025;158:107951.
PubMed

TEODORO LI, Ovsyannikova IG, Grill DE, Poland GA, et al
Seroprevalence of RSV Antibodies in a Contemporary (2022 - 2023) Cohort of Adults.
Int J Infect Dis. 2025 Jun 21:107964. doi: 10.1016/j.ijid.2025.107964.
PubMed Abstract available

JOSEPH JT, Grau-Sepulveda M, Griffith BC, Lufes N, et al
Evaluating the introduction of COVID-19 oral antivirals through a test and treat program: outcomes from a cohort study in four African countries.
Int J Infect Dis. 2025 Jun 19:107956. doi: 10.1016/j.ijid.2025.107956.
PubMed Abstract available

TSUCHIHASHI Y, Tamura K, Matsumoto K, Mitsushima S, et al
Comparative analysis of streptococcal toxic shock syndrome caused by three beta-hemolytic streptococcal species in Japan.
Int J Infect Dis. 2025 Jun 18:107962. doi: 10.1016/j.ijid.2025.107962.
PubMed Abstract available

ESTILL J, Belayneh EG, Beale S, Keiser O, et al
Estimation of the number of people affected by post COVID-19 condition in Switzerland in 2023: A mathematical model.
Int J Infect Dis. 2025 Jun 18:107963. doi: 10.1016/j.ijid.2025.107963.
PubMed Abstract available

WEE LE, Ho RWL, Lim JT, Chiew CJ, et al
Long-term multi-systemic sequelae post-hospitalization for Omicron COVID-19 versus influenza: a retrospective cohort study.
Int J Infect Dis. 2025 Jun 9:107946. doi: 10.1016/j.ijid.2025.107946.
PubMed Abstract available

May 2025

DEBIE Y, Verbruggen L, Peeters M, van Dam PA, et al
mRNA COVID-19 vaccines induce superior IgA titers in cancer patients compared to viral vector vaccines: Implications for immunization strategies.
Int J Infect Dis. 2025 May 23:107939. doi: 10.1016/j.ijid.2025.107939.
PubMed Abstract available

HUANG Q, Kang L, Wei X, Gong C, et al
Epidemiology and genetic diversity of common human coronaviruses in Beijing, 2015-2023: A prospective multicenter study.
Int J Infect Dis. 2025 May 14:107926. doi: 10.1016/j.ijid.2025.107926.
PubMed Abstract available

INZAULE S, Silva R, Thwin SS, Waasila J, et al
In-hospital Mortality Among Children and Adults Hospitalized with COVID-19 in Africa Across Pre-Delta, Delta, and Omicron SARS-CoV-2 Waves.
Int J Infect Dis. 2025 May 7:107924. doi: 10.1016/j.ijid.2025.107924.
PubMed Abstract available

BANHOLZER N, Middelkoop K, Schmutz R, Leukes J, et al
Infection prevention and control measures during the COVID-19 pandemic and airborne tuberculosis transmission during primary care visits in South Africa.
Int J Infect Dis. 2025 May 6:107921. doi: 10.1016/j.ijid.2025.107921.
PubMed Abstract available

April 2025

BERENDS MS, Homburg M, Kupers T, Meijer EN, et al
Impact of Pre-Existing Comorbidities and Multimorbidities, Demography and Viral Variants on Post-Acute Sequelae of COVID-19 ('Long COVID') in Dutch Primary Care: A Retrospective Cohort Study.
Int J Infect Dis. 2025 Apr 19:107912. doi: 10.1016/j.ijid.2025.107912.
PubMed Abstract available

CHEN W, Du M, Deng J, Liu M, et al
Global, regional, and national trends of measles burden and its vaccination coverage among children under five years old: an updated systematic analysis from the Global Burden of Disease study 2021.
Int J Infect Dis. 2025 Apr 15:107908. doi: 10.1016/j.ijid.2025.107908.
PubMed Abstract available

JOLLIVET O, Urchueguia-Fornes A, Chung-Delgado K, Johannesen CK, et al
Respiratory Syncytial Virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre- and post-COVID-19 pandemic.
Int J Infect Dis. 2025 Apr 7:107903. doi: 10.1016/j.ijid.2025.107903.
PubMed Abstract available

March 2025

FANG S, Zhu L, Bai S, Tian W, et al
Year-round infectome profiling of acute febrile respiratory illness unveiled complex epidemiological dynamics post-lifting of COVID-19 restrictions.
Int J Infect Dis. 2025 Mar 29:107896. doi: 10.1016/j.ijid.2025.107896.
PubMed Abstract available

LASTRUCCI V, Pacifici M, Puglia M, Alderotti G, et al
Recent trends in hospitalizations for Respiratory Syncytial Virus after the COVID-19 pandemic and before routine immunization: seasonality and severity updates from the 2023/2024 season in Tuscany, Italy.
Int J Infect Dis. 2025 Mar 13:107879. doi: 10.1016/j.ijid.2025.107879.
PubMed Abstract available

MADEWELL ZJ, Wong JM, Thayer MB, Rivera-Amill V, et al
Population-level respiratory virus-virus interactions, Puerto Rico, 2013-2023.
Int J Infect Dis. 2025 Mar 11:107878. doi: 10.1016/j.ijid.2025.107878.
PubMed Abstract available

LI Z, Wang Z, Wang X, Chen S, et al
Global containment policy duration and long-term epidemic progression: a target trial emulation using COVID-19 data from 2020 to 2022.
Int J Infect Dis. 2025 Mar 5:107871. doi: 10.1016/j.ijid.2025.107871.
PubMed Abstract available

CAMELO S, Dioh W, Teixeira JP, Busse LW, et al
Modulation of the Renin-Angiotensin System against COVID-19: A path forward?
Int J Infect Dis. 2025 Mar 4:107867. doi: 10.1016/j.ijid.2025.107867.
PubMed Abstract available

February 2025

AKHTAR M, Hashmi AH, Manzoor S
The Synergistic Tapestry: unraveling the interplay of Parvovirus B19 with other viruses.
Int J Infect Dis. 2025 Feb 28:107865. doi: 10.1016/j.ijid.2025.107865.
PubMed Abstract available

JOO H, Kim E, Huh K, Bae GH, et al
Risk of Post-Acute Sequelae of COVID-19 and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study.
Int J Infect Dis. 2025 Feb 24:107850. doi: 10.1016/j.ijid.2025.107850.
PubMed Abstract available

SHINZATO A, Hibiya K, Nishiyama N, Ikemiyagi N, et al
Unseasonal respiratory syncytial virus epidemics during the COVID-19 pandemic: relationship between climatic factors and epidemic strain switching.
Int J Infect Dis. 2025 Feb 8:107833. doi: 10.1016/j.ijid.2025.107833.
PubMed Abstract available

LESLIE A, Chapman SA, Tessier KM, Tignanelli C, et al
Beyond the Guidelines: Original Research on Real-World Outcomes of Anticoagulation and Corticosteroid in COVID-19.
Int J Infect Dis. 2025 Feb 8:107834. doi: 10.1016/j.ijid.2025.107834.
PubMed Abstract available

ZAMPIERI F, Michieletto F, Zanatta A
Rise and fall of the Myth of the Good Pathogen in Evolutionary Biology and Medicine.
Int J Infect Dis. 2025 Feb 5:107836. doi: 10.1016/j.ijid.2025.107836.
PubMed Abstract available

January 2025

RICCIO MD, Caini S
Refining Influenza Epidemiology in the Post-COVID-19 Era: The Need for Complementary Approaches.
Int J Infect Dis. 2025 Jan 18:107787. doi: 10.1016/j.ijid.2025.107787.
PubMed

December 2024

PETERSEN E, Hvid U, Tomori O, Pedersen AG, et al
Possible scenarios for the spread of mpox outside the endemic focus in Africa.
Int J Infect Dis. 2024 Dec 27:107373. doi: 10.1016/j.ijid.2024.107373.
PubMed Abstract available

CHEN X, Chen H, Tao F, Chen Y, et al
Global analysis of influenza epidemic characteristics in the first two seasons after lifting the non-pharmaceutical interventions for COVID-19.
Int J Infect Dis. 2024 Dec 20:107372. doi: 10.1016/j.ijid.2024.107372.
PubMed Abstract available

SIBOMANA O, Hakayuwa CM, Munyantore J
Marburg Virus Reaches Rwanda: How Close Are We to a Vaccine Solution?
Int J Infect Dis. 2024 Dec 19:107371. doi: 10.1016/j.ijid.2024.107371.
PubMed Abstract available

WATASE M, Masaki K, Chubachi S, Namkoong H, et al
Corrigendum to 'Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force' [IJID 128 (2023) 121-127].
Int J Infect Dis. 2024;151:107322.
PubMed

ANDEWEG SP, de Kassteele JV, Wang X, van Maarseveen N, et al
Estimating the effect of COVID-19 vaccination and prior infection on Ct values as a proxy of SARS-CoV-2 viral load.
Int J Infect Dis. 2024 Dec 9:107362. doi: 10.1016/j.ijid.2024.107362.
PubMed Abstract available

DEQUIDT T, Richier Q, Louapre C, Ader F, et al
Convalescent plasma in patients receiving Rituximab or Ocrelizumab for Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder with COVID-19: A Multicenter Retrospective Study.
Int J Infect Dis. 2024 Dec 4:107323. doi: 10.1016/j.ijid.2024.107323.
PubMed Abstract available

IP B, Pan S, Yao A, Lau L, et al
COVID-19 vaccination and cerebral small vessel disease progression - A prospective cohort study.
Int J Infect Dis. 2024 Dec 3:107324. doi: 10.1016/j.ijid.2024.107324.
PubMed Abstract available

November 2024

PETT SL
Predictors of hospitalisation, death and incomplete/non-recovery from SARS-CoV-2 in an ambulatory global population.
Int J Infect Dis. 2024 Nov 26:107285. doi: 10.1016/j.ijid.2024.107285.
PubMed Abstract available

YANG X, Zhang J, Liu Z, Chen S, et al
Real-world effectiveness of COVID-19 vaccine in people with HIV compared with a matched HIV-negative cohort: a test-negative design.
Int J Infect Dis. 2024 Nov 22:107310. doi: 10.1016/j.ijid.2024.107310.
PubMed Abstract available

CHUN HM, Osawe S, Adams-Dabban S, Favaloro J, et al
SARS-CoV-2 Serologic Surveillance Among People Living with HIV in Nigeria, April 2022-January 2023.
Int J Infect Dis. 2024 Nov 21:107309. doi: 10.1016/j.ijid.2024.107309.
PubMed Abstract available

VEINTIMILLA C, Miyares AA, Serrano SB, Palomino-Cabrera R, et al
Occult COVID-19 in an immunosuppressed patient with migratory pulmonary infiltrates.
Int J Infect Dis. 2024 Nov 19:107296. doi: 10.1016/j.ijid.2024.107296.
PubMed Abstract available

MELLOR J, Fyles M, Paton RS, Phillips A, et al
Assessing the Impact of SARS-CoV-2 on Influenza-Like Illness Surveillance Trends in the Community during the 2023/2024 Winter in England.
Int J Infect Dis. 2024 Nov 16:107307. doi: 10.1016/j.ijid.2024.107307.
PubMed Abstract available

DE BRUIJN S, Tulen AD, Rodenburg J, Boshuizen H, et al
Post-acute sequalae of COVID-19 three to twelve months after infection: Delta versus Omicron.
Int J Infect Dis. 2024 Nov 14:107302. doi: 10.1016/j.ijid.2024.107302.
PubMed Abstract available

ZAR HJ, Workman L, MacGinty R, Botha M, et al
Natural immunity and protection against variants in South African children through five COVID-19 waves: A prospective study.
Int J Infect Dis. 2024 Nov 13:107300. doi: 10.1016/j.ijid.2024.107300.
PubMed Abstract available

LASTRUCCI V, Pacifici M, Puglia M, Alderotti G, et al
Erratum to 'Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study'.
Int J Infect Dis. 2024;149:107286.
PubMed

GRIFFITHS M, Hatabah D, Sullivan P, Mantus G, et al
Corrigendum to "Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study" [Internation Journal of Infectious Diseases, volume 144 (2024) 107064].
Int J Infect Dis. 2024;149:107278.
PubMed

NAVEED Z, Li J, Wilton J, Naus M, et al
Healthcare utilization among COVID-19 mRNA vaccine-associated myocarditis cases: a matched retrospective cohort study.
Int J Infect Dis. 2024 Nov 1:107287. doi: 10.1016/j.ijid.2024.107287.
PubMed Abstract available

EPSTEIN-SHUMAN A, Hunt JH, Caturegli P, Winguth P, et al
Autoantibodies Directed Against Interferon Alpha, Nuclear Antigens, Cardiolipin, and Beta 2 Glycoprotein 1 Are Not Induced By SARS-CoV-2 or Associated with Long COVID.
Int J Infect Dis. 2024 Nov 1:107289. doi: 10.1016/j.ijid.2024.107289.
PubMed Abstract available

October 2024

AZHAR EI, Velavan TP, Rungsung I, Traore T, et al
Corrigendum to "Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins" [International Journal of Infectious Diseases (2023), volume 131,
Int J Infect Dis. 2024;149:107261.
PubMed

TANG YS, Tan CW, Chong KC, Chen C, et al
Determination of T cell response against XBB variants in adults who received either monovalent wild type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster.
Int J Infect Dis. 2024 Oct 17:107271. doi: 10.1016/j.ijid.2024.107271.
PubMed Abstract available

DE LAZZARI E, Nomah DK, Blanco JL, Rico N, et al
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV. A cross-sectional population-based study.
Int J Infect Dis. 2024 Oct 16:107266. doi: 10.1016/j.ijid.2024.107266.
PubMed Abstract available

ELLINGJORD-DALE M, Nygaard AB, Stoer NC, Bo R, et al
Temporal trajectories of long-COVID symptoms in adults with 22 months follow-up in a prospective cohort study in Norway.
Int J Infect Dis. 2024 Oct 15:107263. doi: 10.1016/j.ijid.2024.107263.
PubMed Abstract available

COLANERI M, Fama F, Fassio F, Holmes D, et al
Impact of Early Antiviral Therapy on SARS-CoV-2 Clearance Time in High-Risk COVID-19 subjects: A Propensity Score Matching Study.
Int J Infect Dis. 2024 Oct 9:107265. doi: 10.1016/j.ijid.2024.107265.
PubMed Abstract available

CELLA E, Fonseca V, Branda F, Tosta S, et al
Integrated analyses of the transmission history of SARS-CoV-2 and its association with molecular evolution of the virus underlining the pandemic outbreaks in Italy, 2019-2023.
Int J Infect Dis. 2024 Oct 8:107262. doi: 10.1016/j.ijid.2024.107262.
PubMed Abstract available

September 2024

NAGASAWA K, Ohata M, Igarashi A, Arashiro T, et al
Prospective hospital-based cohort studies of Respiratory Syncytial Virus (RSV) infections in infants under one year during and after the SARS-CoV-2 pandemic in Japan.
Int J Infect Dis. 2024 Sep 27:107252. doi: 10.1016/j.ijid.2024.107252.
PubMed Abstract available

TAKAHASHI H, Morikawa M, Satake Y, Nagamatsu H, et al
Diagnostic Utility of Pharyngeal Follicular Structures in COVID-19: A Large-scale Cross-Sectional Study.
Int J Infect Dis. 2024 Sep 21:107244. doi: 10.1016/j.ijid.2024.107244.
PubMed Abstract available

LEE JA, Jang H, Ahn SM, Seong JE, et al
Estimates of Vaccine Effectiveness of the Updated Monovalent XBB.1.5 COVID-19 Vaccine Against Symptomatic SARS-CoV-2 Infection, Hospitalization, and Receipt of Oxygen Therapy in South Korea - October 26 to December 31, 2023.
Int J Infect Dis. 2024 Sep 20:107249. doi: 10.1016/j.ijid.2024.107249.
PubMed Abstract available

CERQUEIRA-SILVA T, Boaventura VS, Pearce N, Barral-Netto M, et al
Indirect effectiveness of COVID-19 vaccines in the pre-omicron and omicron periods: a nation-wide test-negative case-control study in Brazil.
Int J Infect Dis. 2024 Sep 18:107241. doi: 10.1016/j.ijid.2024.107241.
PubMed Abstract available

KAWAGUCHI A, Nagaoka K, Kawasuji H, Kawagishi T, et al
COVID-19 complicated with severe M1(UK)-lineage Streptococcus pyogenes infection in elderly patients: A report of two cases.
Int J Infect Dis. 2024 Sep 18:107246. doi: 10.1016/j.ijid.2024.107246.
PubMed Abstract available

MARGALIT I, Weiss-Ottolenghi Y, Panet E, Indenbaum V, et al
SARS-CoV-2 Omicron XBB.1 variant outbreak in a defined cohort: an epidemiological investigation incorporating longitudinal assessment of humoral response.
Int J Infect Dis. 2024 Sep 11:107240. doi: 10.1016/j.ijid.2024.107240.
PubMed Abstract available

SOW SO, Tapia MD, Haidara FC, Diallo F, et al
Safety, reactogenicity, and immunogenicity of ZR-202-CoV and ZR-202a-CoV recombinant vaccines compared with Comirnaty(R): a randomized, observer-blind, controlled, phase 1 study.
Int J Infect Dis. 2024 Sep 11:107237. doi: 10.1016/j.ijid.2024.107237.
PubMed Abstract available

DUARTE-HERRERA ID, Lopez-Martinez C, Rodriguez-Garcia R, Parra D, et al
Identification of host endotypes using peripheral blood transcriptomics in a prospective cohort of patients with endocarditis.
Int J Infect Dis. 2024 Sep 6:107235. doi: 10.1016/j.ijid.2024.107235.
PubMed Abstract available

HUBACEK JA, Capkova N, Bobak M, Pikhart H, et al
Association between FTO polymorphism and COVID-19 mortality among older adults: a population-based cohort study.
Int J Infect Dis. 2024 Sep 5:107232. doi: 10.1016/j.ijid.2024.107232.
PubMed Abstract available

BEEGLE K, Demombynes G, de Walque D, Gubbins P, et al
COVID-19 Increased Existing Gender Mortality Gaps in High Income More than Middle Income Countries.
Int J Infect Dis. 2024 Sep 2:107167. doi: 10.1016/j.ijid.2024.107167.
PubMed Abstract available

August 2024

LASTRUCCI V, Pacifici M, Puglia M, Alderotti G, et al
Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study.
Int J Infect Dis. 2024 Aug 31:107231. doi: 10.1016/j.ijid.2024.107231.
PubMed Abstract available

OKADA Y, Ueda M, Nishiura H
Reconstructing the age-structured case count of COVID-19 from sentinel surveillance data in Japan: a modeling study.
Int J Infect Dis. 2024 Aug 27:107223. doi: 10.1016/j.ijid.2024.107223.
PubMed Abstract available

LOMBARDI A, Colaneri M, Azzara C, Saltini P, et al
Solid organ transplant in recipients with ongoing SARS-CoV-2 infection: A systematic review of case reports and series.
Int J Infect Dis. 2024 Aug 21:107214. doi: 10.1016/j.ijid.2024.107214.
PubMed Abstract available

GALASSI FM, Cofone L, Pindinello I, Ribatti D, et al
The Curfew Bell and the COVID-19 Pandemic: A Historical-Medical Perspective based on the Italian Case.
Int J Infect Dis. 2024 Aug 21:107217. doi: 10.1016/j.ijid.2024.107217.
PubMed Abstract available

KHAN S, Yetiskul E, Khan DF, Khan MWZ, et al
Hantavirus-Induced Cardiac Tamponade: A Diagnostic Dilemma.
Int J Infect Dis. 2024 Aug 16:107212. doi: 10.1016/j.ijid.2024.107212.
PubMed Abstract available

CHOI WJ, Lee J, Choi K, Kim DM, et al
Outcomes of hematopoietic stem cell transplantation in patients with SARS-CoV-2 infection during the Omicron era.
Int J Infect Dis. 2024 Aug 13:107207. doi: 10.1016/j.ijid.2024.107207.
PubMed Abstract available

SONG XD, Yang GJ, Shi C, Jiang XL, et al
Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations.
Int J Infect Dis. 2024 Aug 6:107198. doi: 10.1016/j.ijid.2024.107198.
PubMed Abstract available

KIMURA M, Fujiwara S, Kuroda H, Kanamori M, et al
Choroid plexitis caused by Burkholderia cepacia complex following coronavirus disease 2019.
Int J Infect Dis. 2024 Aug 3:107201. doi: 10.1016/j.ijid.2024.107201.
PubMed Abstract available

ALBERTO RC, Patricia AM, Hugo B, Delia O, et al
Real-world effectiveness of the CoronaVac vaccine in a retrospective population-based cohort in four Colombian Cities 2021-2022.
Int J Infect Dis. 2024 Aug 2:107156. doi: 10.1016/j.ijid.2024.107156.
PubMed Abstract available

July 2024

JANGIAM W, Swangpun K, Iamsirithaworn S, Piriyasatit S, et al
Relative vaccine effectiveness of ChAdOx1/AZD1222 vaccines as booster dose via intradermal injection with a one-fifth dose compared with the intramuscular injection in the prevention of SAR-CoV-2 infections in Phuket - A Retrospective Cohort Study.
Int J Infect Dis. 2024 Jul 31:107179. doi: 10.1016/j.ijid.2024.107179.
PubMed Abstract available

SHU Y, He L, Liu C
Impact of Anti-fibrotic Medications on Post-COVID-19 Pulmonary Fibrosis: A Systematic Review and Meta-analysis.
Int J Infect Dis. 2024 Jul 31:107193. doi: 10.1016/j.ijid.2024.107193.
PubMed Abstract available

THANH TT, Tu NTK, Nguyet LA, Thuy CT, et al
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.
Int J Infect Dis. 2024 Jul 31:107173. doi: 10.1016/j.ijid.2024.107173.
PubMed Abstract available

SUN Y, Dai L, Shan Y, Yang Y, et al
Pathogen characteristics of respiratory infections in the season after the COVID-19 pandemic between August and December 2023: evidence from direct-to-consumer testing-based surveillance in Guangzhou and Beijing, China.
Int J Infect Dis. 2024 Jul 27:107195. doi: 10.1016/j.ijid.2024.107195.
PubMed Abstract available

PEREZ-GUZMAN PN, Chanda SL, Schaap A, Shanaube K, et al
Pandemic burden in low-income settings and impact of limited and delayed interventions: a granular modelling analysis of COVID-19 in Kabwe, Zambia.
Int J Infect Dis. 2024 Jul 25:107182. doi: 10.1016/j.ijid.2024.107182.
PubMed Abstract available

MI X, Zhang X, Dai Z, Yan X, et al
Clinical characteristics and outcomes of lung transplantation in patients with severe COVID-19 infection: A systematic review and meta-analysis.
Int J Infect Dis. 2024 Jul 16:107176. doi: 10.1016/j.ijid.2024.107176.
PubMed Abstract available

SHOJI R, Fukuda K, Mizobuchi T, Arakawa Y, et al
Reactivation of herpes simplex virus 2 presenting as recurrent acute retinal necrosis following COVID-19 vaccination.
Int J Infect Dis. 2024 Jul 16:107170. doi: 10.1016/j.ijid.2024.107170.
PubMed Abstract available

STEMLER J, Yeghiazaryan L, Stephan C, Mohn KG, et al
Immunogenicity, reactogenicity and safety of a second booster with BNT162b2 or full-dose mRNA-1273: a randomised VACCELERATE trial in adults >/=75 years (EU-COVAT-1-AGED Part B).
Int J Infect Dis. 2024 Jul 9:107161. doi: 10.1016/j.ijid.2024.107161.
PubMed Abstract available

LIN DY, Wang J, Anstrom KJ, LaVange LM, et al
Efficacy of Infliximab, Abatacept, and Cenicriviroc for the Treatment of Adults Hospitalized with COVID-19 Pneumonia.
Int J Infect Dis. 2024 Jul 6:107168. doi: 10.1016/j.ijid.2024.107168.
PubMed Abstract available

GUNTHER J, Ziert Y, Andresen K, Pecks U, et al
Variability in COVID-19 Symptom Presentation During Pregnancy and its Impact on Maternal and Infant Outcomes Across the Pandemic.
Int J Infect Dis. 2024 Jul 4:107157. doi: 10.1016/j.ijid.2024.107157.
PubMed Abstract available

ZHENG Y, Jia S, Tang L, Yu L, et al
Recent symptomatic omicron infection reduced COVID-19 pneumonia risk during reinfection: A computed tomography-based cohort study.
Int J Infect Dis. 2024 Jul 4:107164. doi: 10.1016/j.ijid.2024.107164.
PubMed Abstract available

MARTIN-ESCOLANO J, Salto-Alejandre S, Infante-Dominguez C, Carretero-Ledesma M, et al
COVID-19 in patients with haematologic malignancies: effect of RNAemia on clinical outcome in vaccinated patients.
Int J Infect Dis. 2024 Jul 3:107163. doi: 10.1016/j.ijid.2024.107163.
PubMed Abstract available

KHALIL A, Samara A, Campbell H, Ladhani SN, et al
Recent increase in infant pertussis cases in Europe and the critical importance of antenatal immunisations: we must do better...now.
Int J Infect Dis. 2024 Jul 1:107148. doi: 10.1016/j.ijid.2024.107148.
PubMed Abstract available

June 2024

GOH YS, Fong SW, Hor PX, Loh CY, et al
Imprinting of IgA responses in previously infected individuals receiving bivalent mRNA vaccines (WT and BA.4/BA.5 or WT and BA.1).
Int J Infect Dis. 2024 Jun 28:107147. doi: 10.1016/j.ijid.2024.107147.
PubMed Abstract available

TAKASHITA E, Ichikawa M, Fujisaki S, Morita H, et al
Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients.
Int J Infect Dis. 2024 Jun 27:107134. doi: 10.1016/j.ijid.2024.107134.
PubMed Abstract available

DASHTBAN A, Mizani M, Pasea L, Tomlinson C, et al
Vaccinations, cardiovascular drugs, hospitalisation and mortality in COVID-19 and Long COVID.
Int J Infect Dis. 2024 Jun 26:107155. doi: 10.1016/j.ijid.2024.107155.
PubMed Abstract available

CHOI YJ, Kim HN, Lee J, Nham E, et al
Erythema nodosum as an unusual skin manifestation of long COVID: A case report.
Int J Infect Dis. 2024 Jun 25:107152. doi: 10.1016/j.ijid.2024.107152.
PubMed Abstract available

HASEGAWA J, Sekizawa A, Tanaka H, Katsuragi S, et al
Infection route associated with invasive group A streptococcal toxic shock syndrome in maternal deaths: Nationwide analysis of maternal mortalities in Japan.
Int J Infect Dis. 2024 Jun 25:107154. doi: 10.1016/j.ijid.2024.107154.
PubMed Abstract available

WAN EYF, Wang B, Lee AL, Zhou J, et al
Comparative Effectiveness and Safety of BNT162b2 and CoronaVac in Hong Kong: A Target Trial Emulation.
Int J Infect Dis. 2024 Jun 21:107149. doi: 10.1016/j.ijid.2024.107149.
PubMed Abstract available

JEDLICKA P
Furst et al. fail to address crucial biases other than the Healthy vaccinee effect.
Int J Infect Dis. 2024 Jun 20:107143. doi: 10.1016/j.ijid.2024.107143.
PubMed

SMID M, Tucek V, Madar R, Tachezy R, et al
No evidence of a "healthy vaccinee effect" in COVID-19 vaccination data from the Czech Republic.
Int J Infect Dis. 2024 Jun 19:107144. doi: 10.1016/j.ijid.2024.107144.
PubMed

HUIBERTS AJ, van den Hof S, Knol MJ
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022.
Int J Infect Dis. 2024 Jun 18:107127. doi: 10.1016/j.ijid.2024.107127.
PubMed

FARMER G, Sikdar KC, Lo T, Conly J, et al
Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity matched retrospective cohort study of a pan-provincial program in Alberta, Canada.
Int J Infect Dis. 2024 Jun 14:107136. doi: 10.1016/j.ijid.2024.107136.
PubMed Abstract available

May 2024

LOUBET P, Lelievre JD, Francois A, Botelho-Nevers E, et al
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART.
Int J Infect Dis. 2024 May 31:107110. doi: 10.1016/j.ijid.2024.107110.
PubMed Abstract available

DE MENDOZA C, Lozano AB, Rando A, Carmen Nieto MD, et al
The incidence of HIV-2 infection in Spain is declining - a registry data analysis.
Int J Infect Dis. 2024 May 30:107076. doi: 10.1016/j.ijid.2024.107076.
PubMed Abstract available

MAHYUDDIN AP, Swa HLF, Weng R, Zhang J, et al
COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection.
Int J Infect Dis. 2024 May 30:107121. doi: 10.1016/j.ijid.2024.107121.
PubMed Abstract available

REEKIE J, Stovring H, Nielsen H, Johansen IS, et al
Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2.
Int J Infect Dis. 2024 May 25:107111. doi: 10.1016/j.ijid.2024.107111.
PubMed Abstract available

LI Y, Wu Z, Yan Y, Shi Y, et al
Corrigendum to "Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China" [International Journal of Infectious Diseases 139 (2024) pages 6-12].
Int J Infect Dis. 2024;145:107056.
PubMed

RAMONFAUR D, Ayad N, Liu PHZ, Zhou J, et al
The global clinical studies of long COVID.
Int J Infect Dis. 2024 May 21:107105. doi: 10.1016/j.ijid.2024.107105.
PubMed Abstract available

CHEMAITELLY H, Akhtar N, Jerdi SA, Kamran S, et al
Association between COVID-19 vaccination and stroke: a nationwide case-control study in Qatar.
Int J Infect Dis. 2024 May 20:107095. doi: 10.1016/j.ijid.2024.107095.
PubMed Abstract available

ZHANG D, Liu S, Peng B, Shi X, et al
Effects of the timing of maternal SARS-CoV-2 infection and vaccination status on placental transfer of antibodies to neonates: a cross-sectional study.
Int J Infect Dis. 2024 May 16:107098. doi: 10.1016/j.ijid.2024.107098.
PubMed Abstract available

BOJJA D, Zuo S, Townsend JP
Sufficient COVID-19 quarantine and testing on international travelers to forestall cross-border transmission after China's removal of the Zero-COVID policy in early 2023.
Int J Infect Dis. 2024 May 13:107097. doi: 10.1016/j.ijid.2024.107097.
PubMed Abstract available

VAZQUEZ E, de Gregorio-Vicente O, Soriano V, Alvarez-Dominguez C, et al
Increased incidence and mortality from Listeria monocytogenes infection in Spain.
Int J Infect Dis. 2024 May 9:107089. doi: 10.1016/j.ijid.2024.107089.
PubMed Abstract available

KYI D, Xiao Y, Wang X, Feng S, et al
Predominance of A2063G mutant strains in the Mycoplasma pneumoniae epidemic in children-a clinical and epidemiological study in 2023 in Wuhan, China.
Int J Infect Dis. 2024 May 9:107074. doi: 10.1016/j.ijid.2024.107074.
PubMed Abstract available

VAN VOORDEN J, de Groot CJM, Ris-Stalpers C, Afink GB, et al
Corrigendum to "COVID-19 mRNA vaccination during pregnancy does not harm syncytiotrophoblast development" [International Journal of Infectious Diseases, 140C (2024) pages 95-98].
Int J Infect Dis. 2024;144:107068.
PubMed

LIN DY, Xu Y, Gu Y, Sunny SK, et al
Impact of Booster Vaccination Interval on SARS-CoV-2 Infection, Hospitalization, and Death.
Int J Infect Dis. 2024 May 3:107084. doi: 10.1016/j.ijid.2024.107084.
PubMed Abstract available

SCOTT AJ, Limbada M, Perumal T, Jaumdally S, et al
Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa.
Int J Infect Dis. 2024 May 1:107081. doi: 10.1016/j.ijid.2024.107081.
PubMed Abstract available

XIANG Y, Feng Y, Qiu J, Zhang R, et al
Association of COVID-19 vaccination with risks of hospitalization due to cardiovascular and other diseases: a study using data from the UK Biobank.
Int J Infect Dis. 2024 May 1:107080. doi: 10.1016/j.ijid.2024.107080.
PubMed Abstract available

April 2024

MURRAY HC, Muleme M, Cooper D, McNamara BJ, et al
Prevalence, risk factors and outcomes of secondary infections among hospitalised patients with COVID-19 or post-COVID-19 conditions in Victoria, 2020-2023.
Int J Infect Dis. 2024 Apr 30:107078. doi: 10.1016/j.ijid.2024.107078.
PubMed Abstract available

YAN X, Zhao X, Du Y, Wang H, et al
Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: a longitudinal community-based population study in China.
Int J Infect Dis. 2024 Apr 30:107075. doi: 10.1016/j.ijid.2024.107075.
PubMed Abstract available

MARTINEZ-FIERRO ML, Perez-Favila A, Alfaro SMZ, Oropeza-de Lara SA, et al
Gene variants rs5182, rs2074192, and rs4343 in the Renin-Angiotensin-Aldosterone system are associated with symptom severity, higher odds of hospitalization, and death in COVID-19.
Int J Infect Dis. 2024 Apr 30:107067. doi: 10.1016/j.ijid.2024.107067.
PubMed Abstract available

XIE H, Zhang J, Bai S, Lv M, et al
The contributions of vaccination and natural infection to the production of neutralizing antibodies against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) prototype strain and variants.
Int J Infect Dis. 2024 Apr 24:107060. doi: 10.1016/j.ijid.2024.107060.
PubMed Abstract available

VERGORI A, Cozzi-Lepri A, Tavelli A, Mazzotta V, et al
SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T cell counts in people living with HIV.
Int J Infect Dis. 2024 Apr 19:107065. doi: 10.1016/j.ijid.2024.107065.
PubMed Abstract available

GRIFFITHS M, Hatabah D, Sullivan P, Mantus G, et al
Incidence of SARS-CoV-2 Seropositivity in Pediatric Healthcare Workers Prior to Widespread Vaccination: A Five-month Longitudinal Cohort Study.
Int J Infect Dis. 2024 Apr 17:107064. doi: 10.1016/j.ijid.2024.107064.
PubMed Abstract available

RICCIO MD, Caini S, Bonaccorsi G, Lorini C, et al
Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance and Response System (GISRS).
Int J Infect Dis. 2024 Apr 16:107052. doi: 10.1016/j.ijid.2024.107052.
PubMed Abstract available

GLASER N, Diexer S, Klee B, Purschke DO, et al
The contribution of SARS-CoV-2 to the burden of acute respiratory infections in winter season 2022/2023: Results from the DigiHero study.
Int J Infect Dis. 2024 Apr 15:107057. doi: 10.1016/j.ijid.2024.107057.
PubMed Abstract available

GRONING R, Walde J, Ahlm C, Forsell MN, et al
Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: a retrospective cohort study.
Int J Infect Dis. 2024 Apr 12:107046. doi: 10.1016/j.ijid.2024.107046.
PubMed Abstract available

LIEW YX, Ho AYL, Wong GC, Chung SJ, et al
A retrospective study of intravenous pentamidine for PCP prophylaxis in adult patients with hematological malignancies - its utility during respiratory virus pandemics.
Int J Infect Dis. 2024 Apr 12:107059. doi: 10.1016/j.ijid.2024.107059.
PubMed Abstract available

CHEN H, Yu L, Wang L, Zhang J, et al
Demographic characteristics and risk factors for invasive fungal sinusitis in the context of COVID-19: A systematic review and meta-analysis.
Int J Infect Dis. 2024 Apr 11:107054. doi: 10.1016/j.ijid.2024.107054.
PubMed Abstract available

VERGORI A, Lepri AC, Chiuchiarelli M, Mazzotta V, et al
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.
Int J Infect Dis. 2024 Apr 11:107042. doi: 10.1016/j.ijid.2024.107042.
PubMed Abstract available

SLURINK IAL, van den Houdt SCM, Mertens G
Who develops long COVID? Longitudinal pre-pandemic predictors of long COVID and symptom clusters in a representative Dutch population.
Int J Infect Dis. 2024 Apr 10:107048. doi: 10.1016/j.ijid.2024.107048.
PubMed Abstract available

YU J, Zhang K, Chen T, Lin R, et al
Temporal patterns of organ dysfunction in COVID-19 patients hospitalized in the intensive care unit: A group-based multitrajectory modelling analysis.
Int J Infect Dis. 2024 Apr 9:107045. doi: 10.1016/j.ijid.2024.107045.
PubMed Abstract available

FAVRESSE J, Gillot C, Cabo J, David C, et al
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1 and JN.1 six months after the BNT162b2 bivalent booster.
Int J Infect Dis. 2024 Apr 5:107028. doi: 10.1016/j.ijid.2024.107028.
PubMed Abstract available

TAMURA K, Shimbashi R, Kasamatsu A, Chang B, et al
Unveiling the role of preceding seasonal influenza in the development of bacteremic pneumococcal pneumonia in older adults before the COVID-19 pandemic in Japan.
Int J Infect Dis. 2024 Apr 5:107024. doi: 10.1016/j.ijid.2024.107024.
PubMed Abstract available

MARKUSSEN DL, Kommedal O, Knoop ST, Ebbesen MH, et al
Microbial aetiology of community-acquired pneumonia in hospitalized adults: a prospective study utilising comprehensive molecular testing.
Int J Infect Dis. 2024 Apr 4:107019. doi: 10.1016/j.ijid.2024.107019.
PubMed Abstract available

CORRECHER-MARTINEZ E, Lopez-Lacort M, Munoz-Quiles C, Diez-Domingo J, et al
Risk of herpes zoster in adults with SARS-CoV-2 infection in Spain: a population-based, retrospective cohort study.
Int J Infect Dis. 2024 Apr 2:107037. doi: 10.1016/j.ijid.2024.107037.
PubMed Abstract available

March 2024

SALVADORI N, Jourdain G, Krittayaphong R, Siripongboonsitti T, et al
Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: a randomized controlled trial in Thailand.
Int J Infect Dis. 2024 Mar 30:107021. doi: 10.1016/j.ijid.2024.107021.
PubMed Abstract available

WEIRAUCH T, Burger G, Cadar D, Gabriel M, et al
Vaccine-derived Yellow Fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with Sofosbuvir.
Int J Infect Dis. 2024 Mar 21:107017. doi: 10.1016/j.ijid.2024.107017.
PubMed Abstract available

CHEUNG YYH, Lau EHY, Yin G, Lin Y, et al
Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19: a causal inference approach.
Int J Infect Dis. 2024 Mar 21:107012. doi: 10.1016/j.ijid.2024.107012.
PubMed Abstract available

MINK S, Drexel H, Leiherer A, Frick M, et al
Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: a prospective cohort study.
Int J Infect Dis. 2024 Mar 21:107016. doi: 10.1016/j.ijid.2024.107016.
PubMed Abstract available

HOSOZAWA M, Hori M, Hayama-Terada M, Arisa I, et al
Prevalence and risk factors of post-coronavirus disease 2019 condition among children and adolescents in Japan: A matched case-control study in the general population.
Int J Infect Dis. 2024 Mar 12:107008. doi: 10.1016/j.ijid.2024.107008.
PubMed Abstract available

AGUILAR TICONA JP, Xiao M, Li D, Nery JN, et al
Corrigendum to "Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey" [International Journal of Infectious Diseases 139 (2024) 159-167].
Int J Infect Dis. 2024;141:106964.
PubMed

REES C, Swift B, Haldar P
State of art of the detection of M. tuberculosis during TB infection by blood tests using the phage technology.
Int J Infect Dis. 2024 Mar 4:106991. doi: 10.1016/j.ijid.2024.106991.
PubMed Abstract available

February 2024

BOUWMANS P, Malahe SRK, Messchendorp AL, Vart P, et al
Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: a nested case-control study.
Int J Infect Dis. 2024 Feb 28:106990. doi: 10.1016/j.ijid.2024.106990.
PubMed Abstract available

PETRAS M, Janovska D, Lomozova D, Franklova M, et al
Understanding the time-driven shifts of vaccine effectiveness against any and severe COVID-19 before and after the surge of Omicron variants within 2.5 years of vaccination: a meta-regression.
Int J Infect Dis. 2024 Feb 26:106986. doi: 10.1016/j.ijid.2024.106986.
PubMed Abstract available

SYLVAIN L, Donatien K, Kadidia K, Viviane C, et al
SARS-CoV-2 seroprevalence in vaccine-naive participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali.
Int J Infect Dis. 2024 Feb 26:106985. doi: 10.1016/j.ijid.2024.106985.
PubMed Abstract available

DADU A, Yedilbayev A, Migliori GB, Ahmedov S, et al
PASS to End TB in Europe: Accelerated efforts on Prevention and Systematic Screening to End Tuberculosis in the WHO European Region by 2030.
Int J Infect Dis. 2024 Feb 23:S1201-9712(24)00051.
PubMed Abstract available

FURST T, Bazalova A, Frycak T, Janosek J, et al
Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination status and all cause mortality from an analysis of data from 2.2 million individual health records.
Int J Infect Dis. 2024 Feb 22:S1201-9712(24)00046.
PubMed Abstract available

HUANG L, Tong X, Cui J, Du X, et al
Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series.
Int J Infect Dis. 2024;141:106973.
PubMed Abstract available

IKEBE T, Okuno R, Uchitani Y, Yamaguchi T, et al
Epidemiological shifts in and impact of COVID-19 on streptococcal toxic shock syndrome in Japan: A genotypic analysis of Group A Streptococcus isolates.
Int J Infect Dis. 2024 Feb 19:S1201-9712(24)00022.
PubMed Abstract available

BERENTSCHOT JC, Martine Bek L, Heijenbrok-Kal MH, van den Berg-Emons RJG, et al
Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization.
Int J Infect Dis. 2024 Feb 15:S1201-9712(24)00036.
PubMed Abstract available

BIANCHI FP, Rizzi D, Daleno A, Stefanizzi P, et al
Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study.
Int J Infect Dis. 2024 Feb 14:S1201-9712(24)00028.
PubMed Abstract available

TANG Q, Xie X, Peng L, Yang L, et al
Pre-existing Renal Graft Dysfunction As A Major Risk Factor for SARS-CoV-2 Omicron Variant Pneumonia: a Post-Infection Cross-Sectional Study of 312 Immunosuppressed Renal Transplant Recipients.
Int J Infect Dis. 2024 Feb 13:S1201-9712(24)00030.
PubMed Abstract available

DOHERTY TM, Pasquale AD, Finnegan G, Lele J, et al
Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: a scoping review.
Int J Infect Dis. 2024 Feb 12:S1201-9712(24)00031.
PubMed Abstract available

FUENTE A, Postigo T, Ferri FS, Dominguez-Gil M, et al
Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19.
Int J Infect Dis. 2024 Feb 2:S1201-9712(24)00019.
PubMed Abstract available

XIA Q, Yang Y, Wang F, Huang Z, et al
Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents.
Int J Infect Dis. 2024 Feb 1:S1201-9712(24)00018.
PubMed Abstract available

January 2024

VOORDEN AJV, Groot CJM, Ris-Stalpers C, Afink GB, et al
COVID-19 mRNA vaccination during pregnancy does not harm syncytiotrophoblast development.
Int J Infect Dis. 2024 Jan 25:S1201-9712(24)00015.
PubMed Abstract available

December 2023

PUGNI L, Crippa BL, Raimondi F, Vento G, et al
SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: a nationwide prospective cohort study from the Italian Society of Neonatology.
Int J Infect Dis. 2023 Dec 27:S1201-9712(23)00814.
PubMed Abstract available

BOWN A, Sweed A, Catton M, Cowne JN, et al
Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.
Int J Infect Dis. 2023 Dec 25:S1201-9712(23)00813.
PubMed Abstract available

SALMON D, Slama D, Linard F, Dumesges N, et al
Long COVID patients continue to experience significant symptoms at 12 months and factors associated with improvement: a prospective cohort study in France (PERSICOR).
Int J Infect Dis. 2023 Dec 21:S1201-9712(23)00798.
PubMed Abstract available

SILI U MD, PHD, Tekin A MD, Bilgin H MD, MPH, Khan SA MD, et al
Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry.
Int J Infect Dis. 2023 Dec 19:S1201-9712(23)00810.
PubMed Abstract available

MICHAEL F, Mirambo MM, Misinzo G, Minzi O, et al
Trends of measles in Tanzania: a five-year review of case-based surveillance data, 2018-2022.
Int J Infect Dis. 2023 Dec 18:S1201-9712(23)00809.
PubMed Abstract available

TICONA JPA, Xiao M, Li D, Nery N Jr, et al
Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey.
Int J Infect Dis. 2023 Dec 7:S1201-9712(23)00801.
PubMed Abstract available

JUNYONG M, Wang Y, Liu J, Wu Y, et al
Impact of perioperative SARS-CoV-2 Omicron infection on postoperative complications in liver cancer hepatectomy: A single-center matched study.
Int J Infect Dis. 2023 Dec 6:S1201-9712(23)00803.
PubMed Abstract available

SANTOS CAD, Paula AP, Filho GGF, Alves MM, et al
Developmental impairment in children exposed during pregnancy to maternal SARS-COV2: A Brazilian cohort study.
Int J Infect Dis. 2023 Dec 5:S1201-9712(23)00802.
PubMed Abstract available

FINSTERER J, Scorza FA
The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria.
Int J Infect Dis. 2023;137:161.
PubMed

ROSCA EC, Bilavu R, Cornea A, Simu M, et al
The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria - author's reply.
Int J Infect Dis. 2023;137:159-160.
PubMed

BANDA L, Ho A, Kasenda S, Read JM, et al
Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study.
Int J Infect Dis. 2023;137:118-125.
PubMed Abstract available

November 2023

FLORES-GONZALEZ J, Chavez-Galan L, Falfan-Valencia R, Roldan IB, et al
Variant rs4986790 of TLR4 affects the signaling and induces cell dysfunction in severe COVID-19 patients.
Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00793.
PubMed Abstract available

YOSHIMURA M, Sakamoto A, Ozuru R, Kurihara Y, et al
The appearance of anti-spike RBD IgG4 responses after repetitive immunization with mRNA-based COVID-19 vaccines.
Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00789.
PubMed Abstract available

MOSTAGHIM A, Minkove S, Aguilar-Company J, Ruiz-Camps I, et al
Prior immune checkpoint inhibitor (ICI) therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
Int J Infect Dis. 2023 Nov 27:S1201-9712(23)00782.
PubMed Abstract available

TANDLER C, Heitmann JS, Michel TM, Marconato M, et al
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.
Int J Infect Dis. 2023 Nov 26:S1201-9712(23)00770.
PubMed Abstract available

YANG X, Zhang J, Liu Z, Chen S, et al
COVID-19 breakthrough infections among people with and without HIV: a statewide cohort analysis.
Int J Infect Dis. 2023 Nov 25:S1201-9712(23)00790.
PubMed Abstract available

HARRIES M, Jaeger VK, Rodiah I, Hassenstein MJ, et al
Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel.
Int J Infect Dis. 2023 Nov 24:S1201-9712(23)00776.
PubMed Abstract available

NAVARATNAM AM, O'Callaghan C, Beale S, Nguyen V, et al
Eyeglasses and risk of COVID-19 transmission - analysis of the Virus Watch Community Cohort study.
Int J Infect Dis. 2023 Nov 24:S1201-9712(23)00759.
PubMed Abstract available

NGUYEN TTN, Choo EM, Nakamura Y, Suzuki R, et al
Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam.
Int J Infect Dis. 2023 Nov 18:S1201-9712(23)00769.
PubMed Abstract available

LI Y, Wu Z, Yan Y, Shi Y, et al
Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China.
Int J Infect Dis. 2023 Nov 18:S1201-9712(23)00780.
PubMed Abstract available

BELLERBA F, Bardeck N, Boehm M, D'Ecclesiis O, et al
SARS-CoV-2 trends in Italy, Germany and Portugal and school opening during the period of Omicron variant dominance: a quasi-experimental study.
Int J Infect Dis. 2023 Nov 11:S1201-9712(23)00763.
PubMed Abstract available

CHOGA WT, Kurusa Gasenna GK, San JE, Ookame T, et al
Rapid dynamic changes of FL.2 variant: a case report of COVID-19 breakthrough infection.
Int J Infect Dis. 2023 Nov 10:S1201-9712(23)00772.
PubMed Abstract available

DALLMEYER LK, Schuz ML, Fragkou PC, Omony J, et al
Epidemiology of respiratory viruses among children during the SARS-CoV-2 pandemic: A systematic review and meta-analysis.
Int J Infect Dis. 2023 Nov 9:S1201-9712(23)00761.
PubMed Abstract available

LOVELL JF, Miura K, Baik YO, Lee C, et al
One-year Antibody Durability Induced by EuCorVac-19, a Liposome-Displayed COVID-19 RBD Subunit Vaccine, in Healthy Korean Subjects.
Int J Infect Dis. 2023 Nov 7:S1201-9712(23)00765.
PubMed Abstract available

LEE IT, Lin PJ, Yen HH
Pediatric Neuroimaging Findings and Clinical Presentations of COVID-19: A Systematic Review.
Int J Infect Dis. 2023 Nov 7:S1201-9712(23)00767.
PubMed Abstract available

October 2023

AGERGAARD J, Gunst JD, Schiottz-Christensen B, Ostergaard L, et al
Long-term Prognosis at 1.5 years after Infection with Wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron Variants.
Int J Infect Dis. 2023 Oct 29:S1201-9712(23)00760.
PubMed Abstract available

ROSSI G, Salmanton-Garcia J, Cattaneo C, Marchesi F, et al
Age, Successive Waves, Immunization, and Mortality in Elderly COVID-19 Haematological Patients: EPICOVIDEHA Findings.
Int J Infect Dis. 2023 Oct 18:S1201-9712(23)00749.
PubMed Abstract available

RAVLO E, Ianevski A, Starheim E, Wang W, et al
Boosted production of antibodies which neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following mRNA vaccination - a case study.
Int J Infect Dis. 2023 Oct 16:S1201-9712(23)00748.
PubMed Abstract available

SHARMA A, Gupta B, Petersen E, Lee SS, et al
Enhancing preparedness for reducing transmission and globalisation of Antimicrobial Resistance at the Ardh Kumbh Mela 2025, the world's largest recurring religious mass gathering.
Int J Infect Dis. 2023 Oct 16:S1201-9712(23)00751.
PubMed

BERG J, Thies-Lagergren L, Svedenkrans J, Samkutty J, et al
Umbilical cord clamping in the early phases of the COVID-19 era - A systematic review and meta-analysis of reported practice and recommendations in guidelines.
Int J Infect Dis. 2023 Oct 13:S1201-9712(23)00747.
PubMed Abstract available

XU Y, Chen H, Wang B, Zhu X, et al
Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine and measles-mumps-rubella vaccine to healthy infants aged 18 months in China.
Int J Infect Dis. 2023 Oct 11:S1201-9712(23)00743.
PubMed Abstract available

HEJAZI NS, Shen X, Carpp LN, Benkeser D, et al
Stochastic Interventional Approach to Assessing Immune Correlates of Protection: Application to the COVE mRNA-1273 Vaccine Trial.
Int J Infect Dis. 2023 Oct 9:S1201-9712(23)00727.
PubMed Abstract available

SCHUZ ML, Dallmeyer L, Fragkou PC, Omony J, et al
Global prevalence of respiratory virus infections in adults and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.
Int J Infect Dis. 2023 Oct 6:S1201-9712(23)00738.
PubMed Abstract available

INABA M, Miyake Y, Yasuda K
Secondary household transmission of SARS-CoV-2: A case-control study on factors associated with reduced transmission risk.
Int J Infect Dis. 2023 Oct 1:S1201-9712(23)00733.
PubMed Abstract available

GONCALVES YMP, de Assuncao TSF, de Sousa MAD, Ferreira LM Junior, et al
Progressive multifocal leukoencephalopathy triggered by COVID-19 in a previously asymptomatic person living with undiagnosed HIV infection.
Int J Infect Dis. 2023 Oct 1:S1201-9712(23)00730.
PubMed Abstract available

September 2023

FOCOSI D, Maggi F, D'Abramo A, Nicastri E, et al
Antiviral combination therapies for persistent COVID-19 in immunocompromised patients.
Int J Infect Dis. 2023 Sep 29:S1201-9712(23)00734.
PubMed Abstract available

LAI MY, Bukhari FDM, Zulkefli NZ, Ismail I, et al
Corrigendum to "Colorimetric detection of SARS-CoV-2 by uracil-DNA glycosylase (UDG) reverse transcription loop-mediated isothermal amplification (RT-LAMP)" [International Journal of Infectious Diseases 120 (2023) Pages 132-134].
Int J Infect Dis. 2023;136:91.
PubMed

WONG HM, Mun CH, Loke WK, Lim WQ, et al
Moist heat as a promising method to decontaminate N95 masks - a large scale clinical study comparing four decontamination modalities: moist heat, steam, ultraviolet-C irradiation and hydrogen peroxide plasma.
Int J Infect Dis. 2023 Sep 25:S1201-9712(23)00729.
PubMed Abstract available

CASTRO-RODRIGUEZ B, Morales-Jadan D, Viteri-Davila C, Rodriguez AS, et al
"The fake positive results of COVID-19 rapid antigen tests with the use of beverages vary between brands of test kits".
Int J Infect Dis. 2023 Sep 22:S1201-9712(23)00718.
PubMed

GIACOMELLI A, Gagliardini R, Tavelli A, De Benedittis S, et al
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the Icona network.
Int J Infect Dis. 2023 Sep 21:S1201-9712(23)00728.
PubMed Abstract available

PREGER A, Wei R, Berg B, Golomb BA, et al
Covid-19-Associated Rhabdomyolysis: A Scoping Review.
Int J Infect Dis. 2023 Sep 18:S1201-9712(23)00713.
PubMed Abstract available

KAYA H, Tani H, Inasaki N, Yazawa S, et al
Virus evolution and reduced viral viability during treatment of persistent COVID-19 Omicron BA.5 infection in an immunocompromised host.
Int J Infect Dis. 2023 Sep 16:S1201-9712(23)00721.
PubMed Abstract available

HUJAMBERDIEVA LM, Chimed-Ochir O, Yumiya Y, Tanaka J, et al
Relationship between clinical symptom profiles and COVID-19 infection status during delta-dominant period versus omicron-dominant period - analysis of real-world data collected in Hiroshima Prefecture, Japan.
Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00717.
PubMed Abstract available

NAYYERABADI M, Fourcade L, Joshi SA, Chandrasekaran P, et al
Vaccination after developing long COVID: impact on clinical presentation, viral persistence and immune responses.
Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00720.
PubMed Abstract available

CHEMAITELLY H, Faust JS, Krumholz HM, Ayoub HH, et al
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: A national cohort study.
Int J Infect Dis. 2023 Sep 15:S1201-9712(23)00719.
PubMed Abstract available

SSALI I, Mugaba S, Watelo AK, Bemanzi J, et al
Spike Protein is a key target for stronger and more persistent T-Cell Responses - A study of mild and asymptomatic SARS-CoV-2 Infection.
Int J Infect Dis. 2023 Sep 6:S1201-9712(23)00714.
PubMed Abstract available

MIDDELKOOP K, Stewart J, Walker N, Delport C, et al
Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids).
Int J Infect Dis. 2023;134:63-70.
PubMed Abstract available

FAN Y, Gao R, Shang Y, Tian X, et al
Presence of SARS-CoV-2 in middle ear fluid and characterization of otitis media with effusion in COVID-19 patients.
Int J Infect Dis. 2023 Sep 1:S1201-9712(23)00709.
PubMed Abstract available

August 2023

HAUTEFORT C, Corre A, Poillon G, Jourdaine C, et al
Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial.
Int J Infect Dis. 2023 Aug 29:S1201-9712(23)00707.
PubMed Abstract available

YAN X, Li K, Lei Z, Luo J, et al
Prevalence and associated outcomes of co-infection between SARS-CoV-2 and influenza: a systematic review and meta-analysis.
Int J Infect Dis. 2023 Aug 28:S1201-9712(23)00705.
PubMed Abstract available

DIEXER S, Klee B, Gottschick C, Xu C, et al
Association between Virus Variants, Vaccination, Previous Infections, and Post COVID-19 Risk.
Int J Infect Dis. 2023 Aug 25:S1201-9712(23)00702.
PubMed Abstract available

MI Y, Huang L, Liu J, Chao H, et al
High-altitude Resident Pulmonary Edema Induced by SARS-CoV-2 Infection in Children - A Case Series.
Int J Infect Dis. 2023 Aug 21:S1201-9712(23)00700.
PubMed Abstract available

JANHA RE, Bah A, Jah H, Touray F, et al
SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
Int J Infect Dis. 2023 Aug 14:S1201-9712(23)00697.
PubMed Abstract available

EDELSTEIN M, Beiruti KW, Ben-Amram H, Beer N, et al
Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of BNT162b2 - results from 22 months follow-up of a healthcare workers cohort, Israel, 2020-2022.
Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00694.
PubMed Abstract available

CHAE C, Kim RK, Jang EJ, Shim JA, et al
Comparing the Effectiveness of Bivalent and Monovalent COVID-19 Vaccines against COVID-19 Infection during the Winter Season of 2022-2023: A Real-World Retrospective Observational Matched Cohort Study in the Republic of Korea.
Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00695.
PubMed Abstract available

LOW EV, Pathmanathan MD, Chidambaram SK, Kim WR, et al
Real world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk COVID-19 patients during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort study.
Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00688.
PubMed Abstract available

WAILI BA, Yazidi LA, Hashami HA, Gheilani MA, et al
A comparative study of SARS-CoV-2 and common human coronavirus infections among children presenting to tertiary care in Oman.
Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00690.
PubMed Abstract available

DOMNICH A, Orsi A, Ricucci V, De Pace V, et al
Real-world performance of SARS-CoV-2 rapid antigen testing through the Alpha-, Delta- and Omicron-dominant waves of the COVID-19 pandemic.
Int J Infect Dis. 2023 Aug 2:S1201-9712(23)00679.
PubMed Abstract available

TANAKA H, Namkoong H, Chubachi S, Irie S, et al
Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells.
Int J Infect Dis. 2023 Aug 2:S1201-9712(23)00680.
PubMed Abstract available

July 2023

AGUARELES J, Villares-Fernandez P, Carralon-Gonzalez MM, Forne C, et al
Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
Int J Infect Dis. 2023 Jul 21:S1201-9712(23)00661.
PubMed Abstract available

FANG X, Lu K, Sun S, Zhang H, et al
Infection caused by Cupriavidus gilardii in a convalescent COVID-19 patient.
Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00663.
PubMed Abstract available

LIANG W, Lv H, Chen C, Sun Y, et al
Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season - a serological study using retrospective samples collected in Hong Kong.
Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00659.
PubMed Abstract available

TIAN T, Fu L, Lu Z, Wu X, et al
Changes in HPV prevalence, incidence, and clearance among MSM in Xinjiang, China after implementation of nonpharmaceutical interventions to control COVID-19: An interrupted time series analysis.
Int J Infect Dis. 2023 Jul 13:S1201-9712(23)00654.
PubMed Abstract available

HOWARD LM, Huang X, Chen W, Liu Y, et al
Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children.
Int J Infect Dis. 2023 Jul 12:S1201-9712(23)00653.
PubMed Abstract available

ROSCA EC, Bilavu R, Cornea A, Simu M, et al
Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases.
Int J Infect Dis. 2023 Jul 7:S1201-9712(23)00652.
PubMed Abstract available

PUYAT JH, Fowokan A, Wilton J, Janjua NZ, et al
Risk of COVID-19 Hospitalization in People Living with HIV and HIV-Negative Individuals and the Role of COVID-19 Vaccination: A Retrospective Cohort Study.
Int J Infect Dis. 2023 Jul 5:S1201-9712(23)00650.
PubMed Abstract available

COWAN J, Amson A, Christofides A, Chagla Z, et al
Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations.
Int J Infect Dis. 2023 Jul 1:S1201-9712(23)00645.
PubMed Abstract available

June 2023

SIRIPONGBOONSITTI T, Ungtrakul T, Tawinprai K, Nimmol T, et al
Efficacy of Combination Therapy of Fluvoxamine and Favipiravir versus Favipiravir Monotherapy to Prevent Severe COVID-19 among Mild to Moderate COVID-19 Patients: Open-label Randomized Controlled Trial (EFFaCo Study).
Int J Infect Dis. 2023 Jun 29:S1201-9712(23)00641.
PubMed Abstract available

BONNA AS, Pavel SR, Mehjabin T, Ali M, et al
Dengue in Bangladesh.
Int J Infect Dis. 2023 Jun 29:S1201-9712(23)00644.
PubMed Abstract available

MAEDA M, Murata F, Fukuda H
Effect of COVID-19 Vaccination on Household Transmission of SARS-CoV-2 in the Omicron Era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Int J Infect Dis. 2023 Jun 23:S1201-9712(23)00642.
PubMed Abstract available

KANG JM, Kang M, Kim YE, Choi Y, et al
Severe coronavirus disease 2019 in pediatric solid organ transplant recipients: Big data convergence study in Korea (K-COV-N cohort).
Int J Infect Dis. 2023 Jun 21:S1201-9712(23)00640.
PubMed Abstract available

JIAO Y, Zhao J, Wang Z, Chen X, et al
How do Orphan Disease Patients Live Under the Pandemic of Omicron Variant? - A Nationwide Survey of Spinal Muscular Atrophy Patients in China.
Int J Infect Dis. 2023 Jun 21:S1201-9712(23)00639.
PubMed Abstract available

VERGORI A, Matusali G, Lepri AC, Cimini E, et al
Neutralizing activity and T Cell response after bivalent fifth dose of mRNA vaccine in person living with HIV.
Int J Infect Dis. 2023 Jun 19:S1201-9712(23)00632.
PubMed Abstract available

IOANNIDIS JPA, Contopoulos-Ioannidis DG
Pre-pandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: systematic review and meta-analysis.
Int J Infect Dis. 2023 Jun 14:S1201-9712(23)00631.
PubMed Abstract available

MORENO-TORRES V, Martinez-Urbistondo M, Calderon-Parra J, Patricia Mills, et al
COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study.
Int J Infect Dis. 2023 Jun 13:S1201-9712(23)00629.
PubMed Abstract available

COHEN PJF, Rybak DA, Werner DA, Kochert DF, et al
Surveillance of non-invasive group A Streptococcus infections in French ambulatory pediatrics before and during the COVID-19 pandemic: a prospective multicenter study from 2018 to 2022.
Int J Infect Dis. 2023 Jun 6:S1201-9712(23)00622.
PubMed Abstract available

PITA-MARTINEZ C, Perez-Garcia F, Berdices AV, Martin-Vicente M, et al
A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia.
Int J Infect Dis. 2023 Jun 6:S1201-9712(23)00623.
PubMed Abstract available

May 2023

ZHANG R, Wen J, Wu K, Lin S, et al
Influenza-associated neurologic complications in children from an H3N2 outbreak in Shenzhen, China during COVID-19 lockdown.
Int J Infect Dis. 2023 May 30:S1201-9712(23)00616.
PubMed Abstract available

BLANQUART F, Abad C, Ambroise J, Bernard M, et al
Temporal, age and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022.
Int J Infect Dis. 2023 May 12:S1201-9712(23)00539.
PubMed Abstract available

SERVIER C, Porcher R, Pane I, Ravaud P, et al
Trajectories of the evolution of post COVID-19 condition, up to two years after symptoms onset.
Int J Infect Dis. 2023 May 12:S1201-9712(23)00558.
PubMed Abstract available

HUI DS, Yung L, Chan KK, Ng SS, et al
Risk of air and surface contamination during application of different non-invasive respiratory support for patients with COVID-19.
Int J Infect Dis. 2023 May 12:S1201-9712(23)00560.
PubMed Abstract available

MARANGONI D, Antonello RM, Coppi M, Palazzo M, et al
Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: a case report and a scoping review of the literature.
Int J Infect Dis. 2023 May 5:S1201-9712(23)00546.
PubMed Abstract available

KUODI P, Gorelik Y, Gausi B, Bernstine T, et al
Characterisation of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis.
Int J Infect Dis. 2023 May 5:S1201-9712(23)00549.
PubMed Abstract available

ZENS KD, Llanas-Cornejo D, Menges D, Fehr JS, et al
Longitudinal Humoral and Cell-Mediated Immune Responses in a Population-Based Cohort in Zurich, Switzerland from March to June 2022 - Evidence for Protection against Omicron SARS-CoV-2 Infection by Neutralizing Antibodies and Spike-specific T cells.
Int J Infect Dis. 2023 May 4:S1201-9712(23)00538.
PubMed Abstract available

ORLANDO SA, Calderon JL, Leon-Sosa A, Patino L, et al
Corrigendum to ";SARS-CoV-2 transmission from infected owner to household dogs and cats is associated with food sharing" [International Journal of Infectious Diseases, 122 (2022) Pages 295-299].
Int J Infect Dis. 2023;130:214-215.
PubMed

ALBERTO-ORLANDO S, Garcia-Bereguiain MA
Concerns regarding risk factors for SARS-CoV-2 transmission to pets: author's reply.
Int J Infect Dis. 2023;130:212-213.
PubMed

WEESE S
Concerns regarding risk factors for SARS-CoV-2 transmission to pets.
Int J Infect Dis. 2023;130:211.
PubMed

GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
PubMed Abstract available

GOLETTI D, Al-Abri S, Migliori GB, Coler R, et al
World Tuberculosis Day 2023 theme "Yes! We Can End TB!".
Int J Infect Dis. 2023;130 Suppl 1:S1-S3.
PubMed Abstract available

April 2023

TANAKA H, Chubachi S, Asakura T, Namkoong H, et al
Characteristics and Clinical Effectiveness of COVID-19 Vaccination in Hospitalized Patients in Omicron-dominated Epidemic Wave - A Nationwide Study in Japan.
Int J Infect Dis. 2023 Apr 20:S1201-9712(23)00529.
PubMed Abstract available

HUIBERTS AJ, de Gier B, Hoeve CE, de Melker HE, et al
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study.
Int J Infect Dis. 2023 Apr 20:S1201-9712(23)00534.
PubMed Abstract available

MOLINA KC, Kennerley V, Beaty LE, Bennett TD, et al
Real-World Evaluation of Bebtelovimab Effectiveness During the Period of COVID-19 Omicron Variants including BA.4/BA.5.
Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00525.
PubMed Abstract available

COHEN D, Izak M, Stoyanov E, Mandelboim M, et al
Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00526.
PubMed Abstract available

LEE VH, Chan SK, Tam YH, Chau TC, et al
Predictive factors of delayed viral clearance of asymptomatic omicron-related COVID-19 screened positive in cancer patients receiving active anti-cancer treatment.
Int J Infect Dis. 2023 Apr 16:S1201-9712(23)00527.
PubMed Abstract available

YIN S, Ren J, Xue J, Li P, et al
Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries.
Int J Infect Dis. 2023 Apr 15:S1201-9712(23)00522.
PubMed Abstract available

BUTT AA, Guerrero MD, Canlas EB, Al-Dwairi H, et al
Immediate and Contributory Causes of Death in Patients Hospitalized with COVID-19.
Int J Infect Dis. 2023 Apr 13:S1201-9712(23)00514.
PubMed Abstract available

BRYNILDSRUD OB, Watle SV, Alfsnes K, Caugant DA, et al
Invasive meningococcal disease in Norway in the two decades prior to the COVID-19 pandemic.
Int J Infect Dis. 2023 Apr 6:S1201-9712(23)00136.
PubMed Abstract available

March 2023

VON BARTHELD CS, Wang L
The prevalence of olfactory dysfunction with Omicron has decreased in Asia, similar to Western countries.
Int J Infect Dis. 2023 Mar 30:S1201-9712(23)00121.
PubMed

LAWAL BJ, Gallagher KE, Kitonsa J, Tindanbil D, et al
Prevalence of IgG and IgM to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone and Uganda: A Longitudinal Study.
Int J Infect Dis. 2023 Mar 29:S1201-9712(23)00128.
PubMed Abstract available

AZHAR EI, Velavan TP, Rungsung I, Traore T, et al
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - a ten-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins.
Int J Infect Dis. 2023 Mar 28:S1201-9712(23)00125.
PubMed Abstract available

BODNER K, Irvine MA, Kwong JC, Mishra S, et al
Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational Covid-19 studies.
Int J Infect Dis. 2023 Mar 27:S1201-9712(23)00102.
PubMed Abstract available

GUO Y, Wu S, Ye W, Zhao Z, et al
Impact of public health and social measures on contact dynamics during a SARS-CoV-2 Omicron variant outbreak in Quanzhou, China, March to April 2022.
Int J Infect Dis. 2023 Mar 24:S1201-9712(23)00104.
PubMed Abstract available

NAVEED Z, Li J, Naus M, Garcia HAV, et al
A Population-Based Assessment of Myocarditis Following mRNA COVID-19 booster Vaccination Among Adult Recipients.
Int J Infect Dis. 2023 Mar 24:S1201-9712(23)00106.
PubMed Abstract available

LARSEN SE, Baldwin SL, Coler RN
TB Vaccines Update: is an RNA-based vaccine feasible for TB?
Int J Infect Dis. 2023 Mar 22:S1201-9712(23)00114.
PubMed Abstract available

ZINSZER K, Charland K, Pierce L, Saucier A, et al
Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montreal, Canada.
Int J Infect Dis. 2023 Mar 22:S1201-9712(23)00115.
PubMed Abstract available

TAN KS, Ong SWX, Koh MH, Tay DJW, et al
SARS-CoV-2 Omicron variant shedding during respiratory activities.
Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00109.
PubMed Abstract available

WU J, Shi X, Tao B, Zhan Y, et al
Inactivated COVID-19 vaccines booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2.
Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00107.
PubMed Abstract available

DAVIDO B, Jaffal K, Gault E, Bourlet S, et al
Back to the Future of Viruses: A Case of Triple Coinfection caused by RSV, HCov-OC43 and Rhinovirus.
Int J Infect Dis. 2023 Mar 20:S1201-9712(23)00101.
PubMed Abstract available

NAJAFI-FARD S, Aiello A, Navarra A, Cuzzi G, et al
Characterization of the immune impairment of tuberculosis and COVID-19 coinfected patients.
Int J Infect Dis. 2023 Mar 19:S1201-9712(23)00099.
PubMed Abstract available

NEVOLA R, Feola G, Ruocco R, Russo A, et al
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study.
Int J Infect Dis. 2023 Mar 19:S1201-9712(23)00110.
PubMed Abstract available

CHILLON TS, Demircan K, Weiss G, Minich WB, et al
Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters.
Int J Infect Dis. 2023 Mar 16:S1201-9712(23)00095.
PubMed Abstract available

HAMA HO, Chenal T, Pible O, Miotello G, et al
An ancient coronavirus from individuals in France, circa 16(th) century.
Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00093.
PubMed Abstract available

ZANNOLI S, Brandolini M, Marino MM, Denicolo A, et al
SARS-CoV-2 Co-Infection in Immunocompromised Host Leads to Generation of Recombinant Strain.
Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00088.
PubMed Abstract available

MA Y, Gu Y, Shan Z, Huang Y, et al
Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy.
Int J Infect Dis. 2023 Mar 14:S1201-9712(23)00094.
PubMed Abstract available

WANG X, Tang Q, Li H, Jiang H, et al
Autoantibodies against type I interferons in COVID-19 infection: a systematic review and meta-analysis.
Int J Infect Dis. 2023 Mar 10:S1201-9712(23)00087.
PubMed Abstract available

HOUBEN F, den Heijer CD, Dukers-Muijrers NH, Daamen AM, et al
Facility- and ward-level factors associated with SARS-CoV-2 outbreaks among residents in long-term care facilities: a retrospective cohort study.
Int J Infect Dis. 2023 Mar 9:S1201-9712(23)00082.
PubMed Abstract available

THONG PM, Chong HT, Chang AJW, Ong CWM, et al
COVID-19, the escalation of diabetes and the repercussions on Tuberculosis.
Int J Infect Dis. 2023 Mar 8:S1201-9712(23)00055.
PubMed Abstract available

NALUNJOGI J, Mucching-Toscano S, Sibomana JP, Centis R, et al
Impact of COVID-19 on diagnosis of TB, MDR-TB and on mortality in 11 countries in Europe, Northern America and Australia. A Global Tuberculosis Network study.
Int J Infect Dis. 2023 Mar 7:S1201-9712(23)00076.
PubMed Abstract available

VENETI L, Berild JD, Watle SV, Starrfelt J, et al
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022.
Int J Infect Dis. 2023 Mar 7:S1201-9712(23)00080.
PubMed Abstract available

EVANS TS, Tan CW, Aung O, Phyu S, et al
Exposure to diverse sarbecoviruses indicates frequent zoonotic spillover in human communities interacting with wildlife.
Int J Infect Dis. 2023 Mar 2:S1201-9712(23)00064.
PubMed Abstract available

VELAVAN TP, Ntoumi F, Kremsner PG, Lee SS, et al
Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 - the public health challenges.
Int J Infect Dis. 2023;128:307-309.
PubMed

ZILVER SJM, de Groot CJM, Grobben M, Remmelzwaal S, et al
Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate.
Int J Infect Dis. 2023 Mar 1:S1201-9712(23)00071.
PubMed Abstract available

February 2023

KANG W, Yang P, Dang B, Zhang W, et al
Dynamics of disease characteristics and viral RNA decay in patients with asymptomatic and mild infections during the Omicron wave in Shanghai, China: A retrospective cohort study.
Int J Infect Dis. 2023 Feb 25:S1201-9712(23)00067.
PubMed Abstract available

HOWARD-JONES AR, Arnott A, Draper J, Gall M, et al
Emergent Omicron BR.2.1 Sublineage of SARS-CoV-2 in New South Wales, Australia: A Subvariant with High Fitness but Without Increased Disease Severity.
Int J Infect Dis. 2023 Feb 24:S1201-9712(23)00068.
PubMed Abstract available

SANTOS AP, Werneck GL, Dalvi APR, Dos Santos CC, et al
The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2 - The results of ProBCG: A Multicenter Randomized Clinical Trial in Brazil.
Int J Infect Dis. 2023 Feb 23:S1201-9712(23)00065.
PubMed Abstract available

CHANTASRISAWAD N, Techasaensiri C, Kosalaraksa P, Phongsamart W, et al
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.
Int J Infect Dis. 2023 Feb 23:S1201-9712(23)00066.
PubMed Abstract available

PEREIRA PD, Pires MC, Gomes VMR, Nogueira MCA, et al
Clinical characteristics and outcomes of hospital-manifested COVID-19 among Brazilians.
Int J Infect Dis. 2023 Feb 20:S1201-9712(23)00059.
PubMed Abstract available

WU Y, Guo Z, Yuan J, Cao G, et al
Duration of viable virus shedding and PCR positivity of the SARS-CoV-2 Omicron variant in upper respiratory tract: a systematic review and meta-analysis.
Int J Infect Dis. 2023 Feb 17:S1201-9712(23)00057.
PubMed Abstract available

VAIRA LA, De Riu G, Mayo-Yanez M, Gengler IM, et al
Prevalence of chemosensitive disorders with Omicron infections and the possible impacts of vaccination.
Int J Infect Dis. 2023 Feb 15:S1201-9712(23)00054.
PubMed

BELLO-CHAVOLLA OY, Antonio-Villa NE, Valdes-Ferrer SI, Fermin-Martinez CA, et al
Effectiveness of a nation-wide COVID-19 vaccination program in Mexico against symptomatic COVID-19, hospitalizations, and death: a retrospective analysis of national surveillance data.
Int J Infect Dis. 2023 Feb 10:S1201-9712(23)00042.
PubMed Abstract available

BANGAR S, Sonar P, Mane A, Sane S, et al
Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial.
Int J Infect Dis. 2023;129:197-204.
PubMed Abstract available

DE CASTRO MV, Silva MVR, Oliveira LM, Gozzi-Silva SC, et al
"Immunological evaluation of unvaccinated young patients with Turner Syndrome after COVID-19".
Int J Infect Dis. 2023 Feb 7:S1201-9712(23)00044.
PubMed Abstract available

SAITOH H, Sakai-Tagawa Y, Nagasawa S, Torimitsu S, et al
High titers of infectious SARS-CoV-2 in COVID-19 corpses.
Int J Infect Dis. 2023 Feb 6:S1201-9712(23)00047.
PubMed Abstract available

SWETS MC, Moss RJ, Kor F, Hilarius D, et al
A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages.
Int J Infect Dis. 2023 Feb 2:S1201-9712(23)00041.
PubMed Abstract available

LIU C, Lu J, Li P, Feng S, et al
A Comparative study on epidemiological characteristics, transmissibility, and pathogenicity of three COVID-19 outbreaks caused by different variants.
Int J Infect Dis. 2023 Feb 1:S1201-9712(23)00039.
PubMed Abstract available

PATEL S, Truong GT, Rajan A, Creech Z, et al
Discharge Disposition and Clinical Outcomes of Patients Hospitalized with COVID-19.
Int J Infect Dis. 2023 Feb 1:S1201-9712(23)00040.
PubMed Abstract available

January 2023

BANKO A, Miljanovic D, Cirkovic A
Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field.
Int J Infect Dis. 2023 Jan 31:S1201-9712(23)00037.
PubMed Abstract available

SEERY V, Raiden S, Penedo JMG, Borda M, et al
Persistent symptoms after COVID-19 in children and adolescents from Argentina.
Int J Infect Dis. 2023 Jan 31:S1201-9712(23)00033.
PubMed Abstract available

LIU Y, Xu L, Piao X, Li H, et al
Epidemiological, Clinical and Household Transmission Characteristics of Children and Adolescents Infected with SARS-CoV-2 Omicron Variant in Shanghai, China: a Retrospective Multicenter Observational Study.
Int J Infect Dis. 2023 Jan 29:S1201-9712(23)00031.
PubMed Abstract available

PETRONE D, Mateo-Urdiales A, Sacco C, Riccardo F, et al
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
Int J Infect Dis. 2023 Jan 25:S1201-9712(23)00027.
PubMed Abstract available

WU S, Wang L, Dong J, Bao Y, et al
The Dose- and Time-Dependent Effectiveness and Safety Associated with COVID-19 Vaccination During Pregnancy: A Systematic Review and Meta-analysis.
Int J Infect Dis. 2023;128:335-46.
PubMed Abstract available

ATEF S, Hosani FA, AbdelWareth L, Al-Rifai RH, et al
Susceptibility to Reinfection with SARS-CoV-2 Virus Relative to Existing Antibody Concentrations and T cell Response.
Int J Infect Dis. 2023 Jan 23:S1201-9712(23)00005.
PubMed Abstract available

YAMAMOTO S, Matsuda K, Maeda K, Horii K, et al
Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave.
Int J Infect Dis. 2023 Jan 21:S1201-9712(23)00023.
PubMed Abstract available

METCHURTCHLISHVILI R, Chkhartishvili N, Abutidze A, Endeladze M, et al
Effect of remdesivir on mortality and the need for mechanical ventilation among hospitalized COVID-19 patients: real-world data from resource-limited country.
Int J Infect Dis. 2023 Jan 20:S1201-9712(23)00022.
PubMed Abstract available

HELLER M, Henrici C, Buttner J, Leube S, et al
SARS-CoV-2 Neutralizing Antibody Therapies: Early retrospective cohort study of 26 hospitalized patients treated with Bamlanivimab or Casirivimab/Imdevimab.
Int J Infect Dis. 2023 Jan 20:S1201-9712(23)00012.
PubMed Abstract available

NAGGIE S, Milstone A, Castro M, Collins SP, et al
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: A randomized, multicenter, placebo-controlled trial (HERO-HCQ).
Int J Infect Dis. 2023 Jan 19:S1201-9712(23)00019.
PubMed Abstract available

NIYOMNAITHAM S, Jongkaewwattana A, Meesing A, Pinpathomrat N, et al
Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 mRNA vaccine after two doses of CoronaVac vaccines against Delta and Omicron variants.
Int J Infect Dis. 2023 Jan 19:S1201-9712(23)00021.
PubMed Abstract available

SONG J, Jing Q, Zhu E, Liu Q, et al
Alterations in smell or taste in individuals infected with SARS-CoV-2 during periods of Omicron variant dominance.
Int J Infect Dis. 2023 Jan 16:S1201-9712(23)00017.
PubMed Abstract available

HIRAE K, Hoshina T, Koga H
Impact of COVID-19 pandemic on the epidemiology of other communicable diseases in Japan.
Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00013.
PubMed Abstract available

CHEN SH, Wu JL, Liu YC, Yen TY, et al
Differential clinical characteristics and performance of home antigen tests between parents and children following household transmission of SARS-CoV-2 during the Omicron variant pandemic.
Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00014.
PubMed Abstract available

SANTOS VS, Allgayer MF, Kontogianni K, Rocha JE, et al
Pooling of sputum samples to increase tuberculosis diagnostic capacity in Brazil during the COVID-19 pandemic.
Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00011.
PubMed Abstract available

LIN SM, Lee CS, Huang AC, Chiu TH, et al
Effects of Dexamethasone Use on Viral Clearance Among Patients with COVID-19: A Multicenter Cohort Study.
Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00010.
PubMed Abstract available

NUCHNOI P, Piromtong P, Siribal S, Anansilp K, et al
Applicability of a Colorimetric RT-LAMP Assay for SARS-CoV-2 Detection in High Exposure Risk Setting.
Int J Infect Dis. 2023 Jan 12:S1201-9712(23)00009.
PubMed Abstract available

AHSBERG J, Bjerrum S, Ganu VJ, Kwashie A, et al
The in-hospital tuberculosis diagnostic cascade and early clinical outcomes among people living with HIV before and during the COVID-19 pandemic - a prospective multisite cohort study from Ghana.
Int J Infect Dis. 2023 Jan 9:S1201-9712(22)00683.
PubMed Abstract available

JANG YR, Oh YJ, Kim JY
Regdanvimab for patients with mild-to-moderate COVID-19: a retrospective cohort study and subgroup analysis of patients with the Delta variant.
Int J Infect Dis. 2023 Jan 6:S1201-9712(22)00674.
PubMed Abstract available

NGUIPDOP-DJOMO P, Oswald WE, Halliday KE, Cook S, et al
Risk factors for SARS-CoV-2 infection in primary and secondary school students and staff in England in the 2020/2021 school year: a longitudinal study.
Int J Infect Dis. 2023 Jan 5:S1201-9712(22)00673.
PubMed Abstract available

IKEDA M, Okugawa S, Kashiwabara K, Moritoyo T, et al
Multicenter, Single-Blind, Randomized Controlled Study of the Efficacy and Safety of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia.
Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00684.
PubMed Abstract available

BONACINA F, Boelle PY, Colizza V, Lopez O, et al
Global patterns and drivers of influenza decline during the COVID-19 pandemic.
Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00682.
PubMed Abstract available

WEE LE, Tan JY, Oon LLE, Pena AMT, et al
Relapsing COVID-19 infection as a manifestation of Good's syndrome: a case report and literature review.
Int J Infect Dis. 2023 Jan 3:S1201-9712(22)00681.
PubMed Abstract available

December 2022

JOO KIM W, Roberts CC, Young Song J, Yoon JG, et al
Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device.
Int J Infect Dis. 2022 Dec 30:S1201-9712(22)00678.
PubMed Abstract available

JASSAT W, Mudara C, Vika C, Welch R, et al
A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants.
Int J Infect Dis. 2022 Dec 29:S1201-9712(22)00676.
PubMed Abstract available

KOHMER N, Stein S, Schenk B, Grikscheit K, et al
Heterologous prime-boost immunisation with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study.
Int J Infect Dis. 2022 Dec 29:S1201-9712(22)00672.
PubMed Abstract available

MARKL B, Dintner S, Schaller T, Sipos E, et al
Fatal cases after Omicron BA.1 and BA.2 infection: results of an autopsy study.
Int J Infect Dis. 2022 Dec 27:S1201-9712(22)00669.
PubMed Abstract available

YANG SL, Ripen AM, Ven Lee J, Koh K, et al
Time from last immunity event against infection during Omicron dominant period in Malaysia.
Int J Infect Dis. 2022 Dec 26:S1201-9712(22)00667.
PubMed Abstract available

KAIZER AM, Shapiro NI, Wild J, Brown SM, et al
Lopinavir/ritonavir for Treatment of Non-Hospitalized Patients with COVID-19: A Randomized Clinical Trial.
Int J Infect Dis. 2022 Dec 26:S1201-9712(22)00665.
PubMed Abstract available

HEIDARZADEH A, Moridani MA, Khoshmanesh S, Kazemi S, et al
Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test negative case-control study.
Int J Infect Dis. 2022 Dec 23:S1201-9712(22)00664.
PubMed Abstract available

MOHAMMED NI, Mackenzie G, Ezeani E, Sidibeh M, et al
Quantifying Excess Mortality during the Covid-19 pandemic in 2020 in The Gambia: A time-series analysis of three Health and Demographic Surveillance Systems.
Int J Infect Dis. 2022 Dec 22:S1201-9712(22)00654.
PubMed Abstract available

WESTERHOF I, de Hoog M, Ieven M, Lammens C, et al
The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts.
Int J Infect Dis. 2022 Dec 22:S1201-9712(22)00656.
PubMed Abstract available

WATASE M, Masaki K, Chubachi S, Namkoong H, et al
Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: Report based on findings from the Japan COVID-19 Task Force.
Int J Infect Dis. 2022 Dec 20:S1201-9712(22)00655.
PubMed Abstract available

FANO-SIZGORICH D, Vasquez-Velasquez C, Orellana LR, Ponce-Torres C, et al
RISK OF DEATH, HOSPITALIZATION AND ICU ADMISSION BY SARS-CoV-2 VARIANTS IN PERU, A RETROSPECTIVE STUDY.
Int J Infect Dis. 2022 Dec 20:S1201-9712(22)00657.
PubMed Abstract available

PLASSE TF, Delgado B, Potts J, Abramson D, et al
Randomized, placebo-controlled pilot study of upamostat, a host-directed serine protease inhibitor, for outpatient treatment of COVID-19.
Int J Infect Dis. 2022 Dec 19:S1201-9712(22)00638.
PubMed Abstract available

TENE L, Bergroth T, Eisenberg A, Ben David SS, et al
Risk factors, health outcomes, healthcare services utilization, and direct medical costs of long COVID patient.
Int J Infect Dis. 2022 Dec 15:S1201-9712(22)00640.
PubMed Abstract available

PERETA I, Moracho A, Lopez N, Ibanez B, et al
Hospital at Home treatment with Remdesivir for patients with COVID-19: Real life experience.
Int J Infect Dis. 2022 Dec 12:S1201-9712(22)00648.
PubMed Abstract available

NGALAMIKA O, Lidenge SJ, Mukasine MC, Kawimbe M, et al
SARS-CoV-2 Specific T-cell and Humoral Immunity in HIV-infected and -uninfected Individuals in an African Population: A Prospective Cohort Study.
Int J Infect Dis. 2022 Dec 11:S1201-9712(22)00646.
PubMed Abstract available

TORRES C, Garcia J, Mesle F, Barbieri M, et al
Identifying age- and sex-specific COVID-19 mortality trends over time in six countries.
Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00641.
PubMed Abstract available

NGIAM JN, Chhabra S, Goh W, Sim MY, et al
Continued demographic shifts in hospitalised COVID-19 patients from migrant workers to a vulnerable and more elderly local population at risk of severe disease.
Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00643.
PubMed Abstract available

GUO Y, Wang H, Xiao M, Guan X, et al
Long-term outcomes of COVID-19 convalescents: An 18.5-month longitudinal study in Wuhan.
Int J Infect Dis. 2022 Dec 9:S1201-9712(22)00642.
PubMed Abstract available

GARCIA HAV, Adu PA, Harrigan S, Wilton J, et al
Risk factors for COVID-19 hospitalization following COVID-19 Vaccination: a population-based cohort study in Canada.
Int J Infect Dis. 2022 Dec 8:S1201-9712(22)00639.
PubMed Abstract available

LUO Y, Lv H, Zhao S, Sun Y, et al
Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China.
Int J Infect Dis. 2022 Dec 5:S1201-9712(22)00636.
PubMed Abstract available

NYAGWANGE J, Kutima B, Mwai K, Karanja HK, et al
Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.
Int J Infect Dis. 2022 Dec 4:S1201-9712(22)00633.
PubMed Abstract available

VUORIO A, Raal F, Kovanen PT
Drug-drug interaction with oral antivirals for early treatment of COVID-19.
Int J Infect Dis. 2022 Dec 2:S1201-9712(22)00632.
PubMed

LARSEN CS
Drug-drug interaction with oral antivirals for early treatment of COVID-19 - Authors' reply.
Int J Infect Dis. 2022 Dec 2:S1201-9712(22)00631.
PubMed

November 2022

FRIMPONG SO, Paintsil E
Community engagement in Ebola outbreaks in sub-Saharan Africa and implications for COVID-19 control: A scoping review.
Int J Infect Dis. 2022 Nov 30:S1201-9712(22)00625.
PubMed Abstract available

FOWOKAN A, Samji H, Puyat J, Janjua N, et al
Effectiveness of COVID-19 Vaccines in People Living with HIV in British Columbia and comparisons with a matched HIV-Negative Cohort: A Test Negative Design.
Int J Infect Dis. 2022 Nov 30:S1201-9712(22)00624.
PubMed Abstract available

WU S, Li Y, Mishra S, Bodner K, et al
Effect of the incremental protection of previous infection against Omicron infection among individuals with a hybrid of infection- and vaccine-induced immunity: a population-based cohort study in Canada.
Int J Infect Dis. 2022 Nov 28:S1201-9712(22)00620.
PubMed Abstract available

CHUNG HY, Jian MJ, Chang CK, Chen CS, et al
The application of a novel 5-in-1 multiplex RT-PCR assay for rapid detection of SARS-CoV-2 and differentiation between variants of concern.
Int J Infect Dis. 2022 Nov 28:S1201-9712(22)00619.
PubMed Abstract available

DAVIES MA, Morden E, Rosseau P, Arendse J, et al
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
Int J Infect Dis. 2022 Nov 24:S1201-9712(22)00615.
PubMed Abstract available

MIOCH D, Vanbrabant L, Reimerink J, Kuiper S, et al
SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions.
Int J Infect Dis. 2022 Nov 24:S1201-9712(22)00616.
PubMed Abstract available

KANOKUDOM S, Chansaenroj J, Suntronwong N, Assawakosri S, et al
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax(TM)) after homologous and heterologous two-dose regimens.
Int J Infect Dis. 2022 Nov 22:S1201-9712(22)00614.
PubMed Abstract available

BYGDELL M, Leach S, Lundberg L, Gyll D, et al
A comprehensive characterisation of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the ICD-10 diagnosis code (U09.9): a population-based cohort study.
Int J Infect Dis. 2022 Nov 18:S1201-9712(22)00612.
PubMed Abstract available

PUGA-GOMEZ R, Ricardo-Delgado Y, Rojas-Iriarte C, Cespedes-Henriquez L, et al
Open-label phase I/II clinical trial of SARS-CoV-2 RBD-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with RBD-protein vaccine (FINLAY-FR-1A) in children.
Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00601.
PubMed Abstract available

LANGER-GOULD A, Xu S, Myers LC, Chen A, et al
Anakinra or high-dose corticosteroids in COVID-19 pneumonia patients who deteriorate on low-dose dexamethasone: An observational study of comparative effectiveness.
Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00603.
PubMed Abstract available

JUTHI RT, Sazed SA, Sarmin M, Haque R, et al
COVID-19 and Diarrhea: Putative Mechanisms and Management.
Int J Infect Dis. 2022 Nov 17:S1201-9712(22)00602.
PubMed Abstract available

BRUNVOLL SH, Nygaard AB, Fagerland MW, Holland P, et al
Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection.
Int J Infect Dis. 2022 Nov 11. pii: S1201-9712(22)00596.
PubMed Abstract available

INTAWONG K, Chariyalertsak S, Chalom K, Wonghirundecha T, et al
Heterologous third and fourth dose vaccines reduce severity and mortality in COVID-19 patients during the periods of delta and omicron predominance in Thailand.
Int J Infect Dis. 2022 Nov 10. pii: S1201-9712(22)00593.
PubMed Abstract available

LV Y, Yu G, Zhang X, Gu J, et al
Comparative analysis of elderly hospitalized patients with coronavirus disease 2019 or influenza A H1N1 virus infections.
Int J Infect Dis. 2022 Nov 9. pii: S1201-9712(22)00590.
PubMed Abstract available

DECENTI EC, Salvatore MA, Mancon A, Portella G, et al
A large series of molecular and serological specimens to evaluate mother-to-child SARS-CoV-2 transmission: a prospective study from the Italian Obstetric Surveillance System.
Int J Infect Dis. 2022 Nov 8. pii: S1201-9712(22)00584.
PubMed Abstract available

KITAGAWA H, Nomura T, Kaiki Y, Kakimoto M, et al
Viable SARS-CoV-2 detected in the air of hospital rooms of COVID-19 patients with early infection.
Int J Infect Dis. 2022 Nov 7. pii: S1201-9712(22)00589.
PubMed Abstract available

SALDIVAR-ESPINOZA B, Macip G, Pujadas G, Garcia-Vallve S, et al
Could nucleocapsid be a next-generation COVID-19 vaccine candidate?
Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00586.
PubMed

S S, J LR, N W, P M, et al
High prevalence of SARS-CoV-2 antibodies in pregnant women, after the second wave of infections in the inner city of Johannesburg, Gauteng Province, South Africa.
Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00575.
PubMed Abstract available

ORONS B, Larson C, Caroen S, Reid TR, et al
Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's reply.
Int J Infect Dis. 2022 Nov 5. pii: S1201-9712(22)00587.
PubMed

MUHAMMAD AZAMI NA, Perera D, Thayan R, Bakar SA, et al
SARS-CoV-2 genomic surveillance in Malaysia: Displacement of B.1.617.2 with AY lineages as dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
Int J Infect Dis. 2022 Nov 3. pii: S1201-9712(22)00582.
PubMed Abstract available

ALVAREZ-DIAZ DA, Ruiz-Moreno HA, Zapata-Bedoya S, Franco-Munoz C, et al
Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia.
Int J Infect Dis. 2022 Nov 1. pii: S1201-9712(22)00566.
PubMed Abstract available

October 2022

LAKATOS B, Szabo BG, Bobek I, Kiss-Dala N, et al
Baricitinib versus tocilizumab treatment for hospitalized adult patients with severe COVID-19 and associated cytokine storm: A prospective, investigational, real-world study.
Int J Infect Dis. 2022 Oct 31. pii: S1201-9712(22)00577.
PubMed Abstract available

FARRONI C, Aiello A, Picchianti-Diamanti A, Lagana B, et al
Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study.
Int J Infect Dis. 2022 Oct 31. pii: S1201-9712(22)00576.
PubMed Abstract available

MATONO T, Izumiya H, Koga H, Kaku M, et al
Epidemiologic and genomic investigations of an unusual increase in Salmonella enterica serovar Paratyphi A infection among travelers returning from Myanmar in 2015.
Int J Infect Dis. 2022;125:170-176.
PubMed Abstract available

LANGER-GOULD A, Xu S, Myers LC, Chen A, et al
High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness.
Int J Infect Dis. 2022;125:184-191.
PubMed Abstract available

XIN H, Wang Z, Feng S, Sun Z, et al
Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022.
Int J Infect Dis. 2022;126:132-135.
PubMed Abstract available

VISSER MPJ, Walk J, Vermeer C, Bilkova S, et al
Enhanced vitamin K expenditure as a major contributor to vitamin K deficiency in COVID-19.
Int J Infect Dis. 2022;125:275-277.
PubMed Abstract available

CHEN CS, Chang CN, Chen SJ, Hu CF, et al
Workup of cerebral involvement in patients with COVID-19 - authors' reply.
Int J Infect Dis. 2022 Oct 26. pii: S1201-9712(22)00563.
PubMed

SCORZA CA, Finsterer J, Scorza FA, Almeida AG, et al
Workup of cerebral involvement in COVID-19 requires at least cerebral imaging, EEG, and cerebrospinal fluid studies.
Int J Infect Dis. 2022 Oct 20. pii: S1201-9712(22)00564.
PubMed

WANG X, Wen D, He Q, Yang J, et al
Effect of Corticosteroids in Patients with COVID-19: A Bayesian Network Meta-analysis: Corticosteroids in COVID-19.
Int J Infect Dis. 2022 Oct 19. pii: S1201-9712(22)00557.
PubMed Abstract available

SESSA R, Masciullo L, Filardo S, Pietro MD, et al
SARS-CoV-2 vertical transmission in a twin-pregnant woman: a case report.
Int J Infect Dis. 2022 Oct 19. pii: S1201-9712(22)00558.
PubMed Abstract available

BLACKMORE C, Czachorowski M, Farrington E, O'Moore E, et al
Testing for COVID-19 during an outbreak within a large UK prison: an evaluation of mass testing to inform outbreak control.
Int J Infect Dis. 2022 Oct 17. pii: S1201-9712(22)00556.
PubMed Abstract available

DAHL VN, Molhave M, Floe A, van Ingen PJ, et al
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.
Int J Infect Dis. 2022 Oct 13. pii: S1201-9712(22)00551.
PubMed Abstract available

YIN J, Chen Y, Li Y, Wang C, et al
Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis.
Int J Infect Dis. 2022 Oct 11. pii: S1201-9712(22)00542.
PubMed Abstract available

WANG X, Xu H, Chu P, Zeng Y, et al
Effects of COVID-19-targeted NPIs on children's respiratory admissions in China: a national multicenter time series study.
Int J Infect Dis. 2022 Oct 11. pii: S1201-9712(22)00546.
PubMed Abstract available

AGGARWAL NR, Beaty LE, Bennett TD, Carlson NE, et al
Change in Effectiveness of Sotrovimab for Preventing Hospitalization and Mortality for At-risk COVID-19 Outpatients During an Omicron BA.1 and BA.1.1-Predominant Phase.
Int J Infect Dis. 2022 Oct 10. pii: S1201-9712(22)00540.
PubMed Abstract available

MIMURA W, Ishiguro C, Maeda M, Murata F, et al
Effectiveness of mRNA vaccines against SARS-CoV-2 infections during the periods of Delta and Omicron variant predominance in Japan: The VENUS Study.
Int J Infect Dis. 2022 Oct 8. pii: S1201-9712(22)00539.
PubMed Abstract available

DE FREITAS AVC, Magalhaes AM, Carricondo PC, Avakian Shinzato A, et al
Face masks can reduce the frequency of face touching: an observational crossover study.
Int J Infect Dis. 2022;123:54-57.
PubMed Abstract available

September 2022

DAITCH V, Yelin D, Awwad M, Guaraldi G, et al
Characteristics of long COVID among older adults: a cross-sectional study.
Int J Infect Dis. 2022 Sep 30. pii: S1201-9712(22)00535.
PubMed Abstract available

MUADCHIMKAEW M, Siripongboonsitti T, Wongpatcharawarakul S, Boonsankaew C, et al
Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial).
Int J Infect Dis. 2022 Sep 27. pii: S1201-9712(22)00531.
PubMed Abstract available

ALHINAI Z, Park S, Choe YJ, Michelow IC, et al
A global epidemiological analysis of COVID-19 vaccine types and clinical outcomes.
Int J Infect Dis. 2022 Sep 22. pii: S1201-9712(22)00514.
PubMed Abstract available

CHOBER D, Czajkowski Z, Aksak-Was B, Dalewska-Kucharczyk K, et al
Improved survival in ICU in severe COVID-19 associated with amantadine use - retrospective study.
Int J Infect Dis. 2022 Sep 21. pii: S1201-9712(22)00525.
PubMed Abstract available

ZAQOUT A, Almaslamani MA, Chemaitelly H, Hashim SA, et al
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar.
Int J Infect Dis. 2022;124:96-103.
PubMed Abstract available

TAMURA D, Yamagishi H, Morisawa Y, Mato T, et al
Diagnostic accuracy of a novel severe acute respiratory syndrome coronavirus 2 rapid antigen test and usefulness of specimens collected from the anterior nasal cavity.
Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00517.
PubMed Abstract available

FENIZIA C, Vanetti C, Rana F, Cappelletti G, et al
SARS-CoV-2 vertical transmission during the first trimester of pregnancy in asymptomatic women.
Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00520.
PubMed Abstract available

KUBO M, Kubo K, Kobayashi KI, Komiya N, et al
Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review.
Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00508.
PubMed Abstract available

ANDO M, Satonaga Y, Takaki R, Yabe M, et al
Acute asthma exacerbation due to SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine [Comirnaty(R)]).
Int J Infect Dis. 2022 Sep 16. pii: S1201-9712(22)00518.
PubMed Abstract available

VICENTINI C, Bordino V, Cornio AR, Meddis D, et al
Seroprevalence of infection-induced SARS-CoV-2 antibodies among healthcare users of Northern Italy - results from two serosurveys (October-November 2019 - September-October 2021).
Int J Infect Dis. 2022 Sep 15. pii: S1201-9712(22)00513.
PubMed Abstract available

ROTUNDO S, Vecchio E, Abatino A, Giordano C, et al
Spike-specific T-cell responses in COVID-19 patients successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2.
Int J Infect Dis. 2022 Sep 15. pii: S1201-9712(22)00515.
PubMed Abstract available

KIM AY, Woo W, Yon DK, Lee SW, et al
Corrigendum to 'Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis' International Journal of Infectious Diseases, Volume 119, June 2022, Page 130-139.
Int J Infect Dis. 2022;123:166.
PubMed

D'ABRAMO A, Vita S, Colavita F, Cimini E, et al
The first case of meningitis associated to SARS-Coronavirus-2 BA.2 variant infection with persistent viremia.
Int J Infect Dis. 2022 Sep 12. pii: S1201-9712(22)00510.
PubMed Abstract available

ANTONAZZO IC, Fornari C, Rozza D, Conti S, et al
Azithromycin use and outcomes in COVID-19 patients: an observational real-world study.
Int J Infect Dis. 2022 Sep 8. pii: S1201-9712(22)00504.
PubMed Abstract available

GIUSEPPE S, Guarini R, Vaia F, Maggi F, et al
Monitoring of SARS-CoV-2 circulation using saliva testing in school children, Rome, Italy.
Int J Infect Dis. 2022 Sep 8. pii: S1201-9712(22)00502.
PubMed Abstract available

ZAYET S, Vuillemenot JB, Josset L, Gendrin V, et al
Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing.
Int J Infect Dis. 2022 Sep 7. pii: S1201-9712(22)00501.
PubMed Abstract available

CHEN CS, Chang CN, Hu CF, Jian MJ, et al
Critical pediatric neurological illness associated with COVID-19 (Omicron BA.2.3.7 variant) infection in Taiwan: Immunological assessment and viral genome analysis in tertiary medical center.
Int J Infect Dis. 2022 Sep 7. pii: S1201-9712(22)00500.
PubMed Abstract available

ABROI A, Talas UG, Pauskar M, Shablinskaja A, et al
SARS-CoV-2 dual infection of Delta and Omicron variants in an immunocompetent host - a case report.
Int J Infect Dis. 2022 Sep 5. pii: S1201-9712(22)00497.
PubMed Abstract available

LI YE, Wang S, Reiter RJ, Ren J, et al
Clinical Cardiovascular Emergencies and the Cellular Basis of COVID-19 Vaccination: from a Dream to Reality?
Int J Infect Dis. 2022 Sep 5. pii: S1201-9712(22)00498.
PubMed Abstract available

LEE SS, Viboud C, Petersen E
Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control.
Int J Infect Dis. 2022;122:1002-1004.
PubMed

August 2022

WAITS A, Chen JY, Cheng WH, Yeh JI, et al
Safety and Immunogenicity of MVC-COV1901 Vaccine in Older Adults: Phase 2 Randomized Dose-Comparison Trial.
Int J Infect Dis. 2022 Aug 29. pii: S1201-9712(22)00491.
PubMed Abstract available

BRUNNER WM, Freilich D, Victory J, Krupa N, et al
Comparison of Antibody Response Durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 Vaccines in Healthcare Workers.
Int J Infect Dis. 2022 Aug 28. pii: S1201-9712(22)00492.
PubMed Abstract available

ASSERI AA, Assiri M, Alshehri MA, Asseri M, et al
Acute Encephalopathy in a 6-Year-Old Child with Concurrent Coronavirus Disease-2019 Infection: A Case Report from Saudi Arabia.
Int J Infect Dis. 2022 Aug 20. pii: S1201-9712(22)00483.
PubMed Abstract available

SAINZ-GARCIA A, Toledano P, Muro-Fraguas I, Alvarez-Erviti L, et al
Mask Disinfection using Atmospheric Pressure Cold Plasma.
Int J Infect Dis. 2022 Aug 19. pii: S1201-9712(22)00482.
PubMed Abstract available

OEHLER RL, Vega VR
Global Vaccine Inequality Threatens to Unleash the Next COVID-19 Variant.
Int J Infect Dis. 2022 Aug 18. pii: S1201-9712(22)00480.
PubMed Abstract available

GHAFFARZADEGAN N
Effect of mandating vaccination on COVID-19 cases in colleges and universities.
Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00477.
PubMed Abstract available

VIEL S, Markowicz S, Ait-Medjber L, Ouissa R, et al
Dedicated team to ambulatory care for patients with COVID-19 requiring oxygen: low rate of hospital readmission.
Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00452.
PubMed Abstract available

YU T, Liu F, Yin H, Yi N, et al
Comment to the article by Pedro Brotons: Validation and implementation of a direct RT-qPCR method for rapid screening of SARS-CoV-2 infection by using non-invasive saliva samples, IJID 110 (2021) 363-370.
Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00478.
PubMed

SANCHEZ-CONDE M, Vizcarra P, Perez-Garcia JM, Gion M, et al
Pembrolizumab in combination with tocilizumab in high-risk hospitalized COVID-19 patients (COPERNICO): A randomized proof-of-concept phase II study.
Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00475.
PubMed Abstract available

NAVARATNAM AMD, Shrotri M, Nguyen V, Braithwaite I, et al
Nucleocapsid and spike antibody responses post virologically confirmed SARS-CoV-2 infection: An observational analysis in the Virus Watch community cohort.
Int J Infect Dis. 2022 Aug 17. pii: S1201-9712(22)00449.
PubMed Abstract available

RAYMENANTS J, Duthoo W, Stakenborg T, Verbruggen B, et al
Exhaled breath SARS-CoV-2 shedding patterns across variants of concern.
Int J Infect Dis. 2022 Aug 3. pii: S1201-9712(22)00466.
PubMed Abstract available

LIANG Y, Mao X, Kuang M, Zhi J, et al
IL-6 affects the severity of olfactory disorder: A cross-sectional survey of 148 patients who recovered from Omicron infection using the Sniffin' Sticks test in Tianjin, China.
Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00468.
PubMed Abstract available

ALMADHI M, Alsayyad AS, Conroy R, Atkin S, et al
EPIDEMIOLOGICAL ASSESSMENT OF SARS-COV-2 REINFECTION.
Int J Infect Dis. 2022 Aug 2. pii: S1201-9712(22)00470.
PubMed Abstract available

July 2022

DE OLIVEIRA JF, de Avila RE, de Oliveira NR, da Cunha Severino Sampaio N, et al
Persistent symptoms, quality of life and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil.
Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00458.
PubMed Abstract available

SRECKOVIC M, Marjanovic RR, Jovicic BP, Jankovic S, et al
MULTISYSTEM INFLAMMATORY SYNDROME IN YOUNG ADULT SUCCESSFULLY TREATED WITH PLASMAPHERESIS, IMMUNOGLOBULINS AND CORTICOSTEROIDS: A CASE REPORT.
Int J Infect Dis. 2022 Jul 28. pii: S1201-9712(22)00454.
PubMed Abstract available

LI T, Song R, Wang J, Zhang J, et al
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer.
Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00446.
PubMed Abstract available

DAHAL S, Mamelund SE, Luo R, Sattenspiel L, et al
Investigating COVID-19 transmission and mortality differences among Indigenous and non-Indigenous populations in Mexico.
Int J Infect Dis. 2022 Jul 26. pii: S1201-9712(22)00447.
PubMed Abstract available

AIELLO A, Coppola A, Vanini V, Petrone L, et al
Accuracy of QuantiFERON SARS-CoV-2 RUO assay and characterization of the CD4(+) and CD8(+) T-cell-SARS-CoV-2 response: comparison with a homemade IFN-gamma release assay.
Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00444.
PubMed Abstract available

DORIA G, Clemente C, Coelho E, Colaco J, et al
An isothermal lab-on-phone test for easy molecular diagnostic of SARS-CoV-2 near patient and in less than 1 hour.
Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00436.
PubMed Abstract available

VALLADARES-GARRIDO MJ, Failoc-Rojas VE, Soto-Becerra P, Zena-Nanez S, et al
Clinical-epidemiological variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.
Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00442.
PubMed Abstract available

VILLAFUERTE DB, Lavrynenko O, Qazi R, Passeri MF, et al
Chronic Active Epstein-Barr Exacerbated by COVID-19 Co-Infection.
Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00439.
PubMed Abstract available

AKHMETZHANOV AR, Ponce L, Thompson RN
Emergence potential of Monkeypox in the Western Pacific Region, July 2022.
Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00441.
PubMed Abstract available

LU J, Zhu J, Zhu J, Duong TQ, et al
LSTM machine learning of longitudinal clinical data accurately predicts acute kidney injury onset in COVID-19: a two-center study.
Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00429.
PubMed Abstract available

ASSAWAKOSRI S, Kanokudom S, Chansaenroj J, Suntronwong N, et al
Persistence of immunity against Omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination.
Int J Infect Dis. 2022 Jul 18. pii: S1201-9712(22)00433.
PubMed Abstract available

BAIRD D, Muir A, Logan L, MacLennan M, et al
Validation of the NeuMoDx SARS-CoV-2 Assay with COPAN eNAT(R) and E&O Viral PCR Sample Solution (VPSS) collection media types in comparison with other validated SARS-CoV-2 RNA assays.
Int J Infect Dis. 2022 Jul 15. pii: S1201-9712(22)00418.
PubMed Abstract available

BHATNAGAR T, Chaudhuri S, Ponnaiah M, Yadav PD, et al
Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: A multi-centric hospital-based case-control study.
Int J Infect Dis. 2022 Jul 14. pii: S1201-9712(22)00427.
PubMed Abstract available

YIN Q, Li Y, Pan H, Hui T, et al
Atypical pneumonia caused by Chlamydia Psittaci during the COVID-19 pandemic.
Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00422.
PubMed Abstract available

VOOR IN 'T HOLT AF, Haanappel CP, Rahamat-Langendoen J, Molenkamp R, et al
Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 PCR positivity: primary, contributing, or incidental COVID-19.
Int J Infect Dis. 2022 Jul 13. pii: S1201-9712(22)00424.
PubMed Abstract available

MAAMARI KA, Busaidi IA, Kindi MA, Zadjali F, et al
Short and long-term immune changes in different severity groups of COVID-19 disease.
Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00421.
PubMed Abstract available

ALOTAIBY M, Krissaane I, Seraihi AA, Alshenaifi J, et al
SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00420.
PubMed Abstract available

JUANOLA-FALGARONA M, Penarrubia L, Jimenez-Guzman S, Porco R, et al
Ct values as a diagnostic tool for monitoring SARS-CoV-2 viral load using the QIAstat-Dx(R) Respiratory SARS-CoV-2 Panel.
Int J Infect Dis. 2022 Jul 12. pii: S1201-9712(22)00419.
PubMed Abstract available

TOCZYLOWSKI K, Lasecka-Zadrozna J, Palyga-Bysiecka I, Ludwikowska KM, et al
Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study.
Int J Infect Dis. 2022 Jul 10. pii: S1201-9712(22)00416.
PubMed Abstract available

DASTENAE ZH, Bahadori A, Dehghani M, Asadi-Samani M, et al
Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial.
Int J Infect Dis. 2022 Jul 8. pii: S1201-9712(22)00413.
PubMed Abstract available

PETERSEN MS, Kongsstovu SI, Eliasen EH, Larsen S, et al
Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands.
Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00405.
PubMed Abstract available

NATH H, Mallick A, Roy S, Kayal T, et al
COVID-19 serum can be cross-reactive and neutralizing against Dengue virus (DV) as observed by DV neutralization test.
Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00408.
PubMed Abstract available

BIBER A, Harmelin G, Lev D, Ram L, et al
The effect of ivermectin on the viral load and culture viability in early treatment of non-hospitalized patients with mild COVID-19 - A double-blind, randomized placebo-controlled trial.
Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00399.
PubMed Abstract available

FUKUSHIMA T, Chubachi S, Namkoong H, Otake S, et al
U-shaped association between abnormal serum uric acid levels and COVID-19 severity: Reports from the Japan COVID-19 Task Force.
Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00409.
PubMed Abstract available

MURUGESAN M, Venkatesan P, Kumar S, Thangavelu P, et al
Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS).
Int J Infect Dis. 2022 Jul 7. pii: S1201-9712(22)00402.
PubMed Abstract available

RICCIARDI A, Zelini P, Cassaniti I, Avanzini MA, et al
Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: Prolonged protection from SARS-CoV-2 in newborns and older children.
Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00392.
PubMed Abstract available

TOBBACK E, Degroote S, Buysse S, Delesie L, et al
Efficacy and safety of camostat mesylate in early Covid-19 disease in an ambulatory setting: A randomized placebo-controlled phase II trial.
Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00388.
PubMed Abstract available

MALINOWSKA J, Malecka-Gieldowska M, Bankowska D, Borecka K, et al
Hypermagnesemia and hyperphosphatemia are highly prevalent in COVID-19 patients and increase the risk of death.
Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00394.
PubMed Abstract available

SALEH T, Kerin T, Fuller T, Paiola S, et al
Clinical and epidemiological characteristics of SARS-CoV-2 Infection in Los Angeles County youth during the first year of the pandemic.
Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00374.
PubMed Abstract available

LARSEN CS
Assessing the proportion of the Danish population at risk of clinically significant drug-drug interactions with new oral antivirals for early treatment of COVID-19.
Int J Infect Dis. 2022 Jul 5. pii: S1201-9712(22)00391.
PubMed Abstract available

DESWAL V, Phogat R, Sharma P, Kataria S, et al
Is single dose of ChAdOx1 nCoV-19 vaccine (AZD1222) enough for persons with prior SARS-CoV-2 infection or baseline seropositive status?
Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00384.
PubMed

DING L, Chen Y, Su N, Xu X, et al
Comparison of acute respiratory distress syndrome in patients with COVID-19 and influenza A (H7N9) virus infection.
Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00387.
PubMed Abstract available

KOH K, Tang KC, Axhausen K, Loo BP, et al
A metropolitan-scale, three-dimensional agent-based model to assess the effectiveness of the COVID-19 Omicron wave interventions in a hyperdense city: a case study of Hong Kong.
Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00376.
PubMed Abstract available

XIONG L, Li Q, Cao X, Xiong H, et al
Recovery of functional fitness, lung function and immune function in health care workers with non-severe and severe COVID-19 at 13 months after discharge from the hospital: a prospective cohort study.
Int J Infect Dis. 2022 Jul 3. pii: S1201-9712(22)00386.
PubMed Abstract available

CHEN NY, Liu ZH, Kao SW, Lin HS, et al
Changes in Interferon-Gamma Release Assay Readout after COVID-19 Vaccination: A Prospective Cohort Study.
Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00382.
PubMed Abstract available

ORONSKY B, Larson C, Caroen S, Hedjran F, et al
Nucleocapsid as a Next Generation COVID-19 Vaccine Candidate.
Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00379.
PubMed Abstract available

ISA F, Forleo-Neto E, Meyer J, Zheng W, et al
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Int J Infect Dis. 2022 Jul 1. pii: S1201-9712(22)00380.
PubMed Abstract available

June 2022

FARIDL M, Mellyani K, Khoirunnisa K, Septiani P, et al
RNA-seq analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic COVID-19 patients.
Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00368.
PubMed Abstract available

DOS SANTOS PG, Vieira HCVS, Wietholter V, Gallina JP, et al
When to test for COVID-19 using RT-PCR: a systematic review.
Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00370.
PubMed Abstract available

SBERNA G, Fabeni L, Berno G, Carletti F, et al
Rapid and qualitative identification of SARS-CoV-2 mutations associated with Variants Of Concern (VOC) using a multiplex RT-PCR assay coupled with melting analysis.
Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00367.
PubMed Abstract available

HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
Classification of Omicron BA.1, BA.1.1 and BA.2 sublineages by TaqMan assay consistent with whole genome analysis data.
Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00373.
PubMed Abstract available

FINSTERER J, Scorza FA
Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination: COVID-19 associated abdominal epilepsy.
Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00372.
PubMed

KAMURA Y, Matsue K
Severe rhabdomyolysis and SARS-CoV-2 vaccination: A reply to the letter by Dr Josef Finsterer.
Int J Infect Dis. 2022 Jun 24. pii: S1201-9712(22)00366.
PubMed

PETERSEN MS, Kristiansen MF, Hanusson KD, Foldbo BM, et al
Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months follow up.
Int J Infect Dis. 2022 Jun 23. pii: S1201-9712(22)00364.
PubMed Abstract available

RUTER J, Pallerla SR, Meyer CG, Casadei N, et al
Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19.
Int J Infect Dis. 2022 Jun 23. pii: S1201-9712(22)00365.
PubMed Abstract available

KSHATRI JS, Giri S, Bhattacharya D, Palo SK, et al
Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level- findings from the ICMR- Hundred Million Test (HMT) database during the first wave in India.
Int J Infect Dis. 2022 Jun 22. pii: S1201-9712(22)00361.
PubMed Abstract available

ROVIDA F, Esposito GL, Rissone M, Novelli V, et al
Characteristics and outcome of vaccinated and non-vaccinated patients hospitalized in a single Italian HUB for COVID-19 during the Delta and Omicron waves in Northern Italy.
Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00362.
PubMed Abstract available

RIZZO R, Bortolotti D, Morandi L, Rizzo S, et al
Humoral and adaptive immune responses to SARS-CoV-2 vaccine.
Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00355.
PubMed Abstract available

QUARANTA EG, Fusaro A, Giussani E, D'Amico V, et al
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00359.
PubMed Abstract available

STAMBOULI N, Driss A, Gargouri F, Bahrini K, et al
COVID-19 prophylaxis with Doxycycline and Zinc in Health Care Workers: A prospective randomized double-blind clinical trial.
Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00349.
PubMed Abstract available

QIN J, Wang G, Han D
Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis.
Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00348.
PubMed Abstract available

KOLLER JE, Villinger K, Lages NC, Absetz P, et al
Individual and collective protective responses during the early phase of the COVID-19 pandemic in 10 different countries: Results from the EUCLID online-survey.
Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00347.
PubMed Abstract available

CLARO F, Silva D, Bogado JAP, Rangel HR, et al
Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V.
Int J Infect Dis. 2022 Jun 8. pii: S1201-9712(22)00341.
PubMed Abstract available

TARNAS MC, Desai AN, Parker DM, Almhawish N, et al
Syndromic surveillance of respiratory infections during protracted conflict: experiences from northern Syria 2016-2021.
Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00336.
PubMed Abstract available

SASANAMI M, Kayano T, Nishiura H
Monitoring the COVID-19 immune landscape in Japan.
Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00338.
PubMed Abstract available

MANNATHOKO N, Mospele M, Gross R, Smith RM, et al
Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00337.
PubMed Abstract available

KHONGYOT T, Moriyasu T
Invasive Pneumococcal Disease diminish during the coronavirus disease 2019 in Japan between 2019 and 2022.
Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00333.
PubMed Abstract available

HERNANDEZ PORTO M, Garcia S, Delgado T, Rodriguez Y, et al
Humoral response to SARS-COV-2 after vaccination and C in dialyzed patients.
Int J Infect Dis. 2022 Jun 4. pii: S1201-9712(22)00335.
PubMed Abstract available

DIVINO F, Alaimo Di Loro P, Farcomeni A, Jona-Lasinio G, et al
Decreased severity of the Omicron variant of concern: further evidence from Italy.
Int J Infect Dis. 2022;119:21-23.
PubMed

May 2022

LAI X, Deng S, Hu L, Chen R, et al
J-shaped associations and joint effects of fasting glucose with inflammation and cytokines on COVID-19 mortality.
Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00324.
PubMed Abstract available

BORDI L, Sberna G, Piscioneri CN, Cocchiara RA, et al
Longitudinal dynamics of SARS-CoV2 anti-Receptor Binding Domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccination.
Int J Infect Dis. 2022 May 31. pii: S1201-9712(22)00325.
PubMed Abstract available

BACHELARD A, Sautereau A, Digumber M, Isernia V, et al
Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1.
Int J Infect Dis. 2022 May 29. pii: S1201-9712(22)00320.
PubMed

JIN T, Chen X, Nishio M, Zhuang L, et al
Interventions to prevent surface transmission of an infectious virus based on real human touch behavior: A case study of the norovirus.
Int J Infect Dis. 2022 May 29. pii: S1201-9712(22)00311.
PubMed Abstract available

ALBERTO-ORLANDO S, Calderon JL, Leon-Sosa A, Patino L, et al
SARS-CoV-2 transmission from infected owner to household dogs and cats is associated to food sharing.
Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00313.
PubMed Abstract available

TEGETHOFF SA, Danziger G, Kuhn D, Kimmer C, et al
TRAIL, IP-10, and CRP in predicting the progression of SARS-CoV-2 infection: A prospective, cohort study.
Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00315.
PubMed Abstract available

ALI M, Bonna AS, Sarkar AS, Islam MA, et al
SARS-CoV-2 infection is associated with low back pain: Findings from a community based case-control study.
Int J Infect Dis. 2022 May 25. pii: S1201-9712(22)00312.
PubMed Abstract available

WAWINA-BOKALANGA T, Logist AS, Sinnesael R, Van Holm B, et al
Genomic evidence of co-identification with Omicron and Delta SARS-CoV-2 variants: A report of two cases.
Int J Infect Dis. 2022 May 20. pii: S1201-9712(22)00304.
PubMed Abstract available

KORAYEM GB, Aljuhani O, Altebainawi AF, Shaya AIA, et al
The Safety and Efficacy of Tocilizumab in Older Adult Critically Ill Patients with Coronavirus Disease 2019 (COVID-19): A Multi-center, Cohort Study.
Int J Infect Dis. 2022 May 20. pii: S1201-9712(22)00302.
PubMed Abstract available

MATTIUZZI C, Lippi G
Real-world effectiveness of COVID-19 vaccination among children in Italy.
Int J Infect Dis. 2022 May 19. pii: S1201-9712(22)00309.
PubMed Abstract available

NTAGEREKA PB, Oyola SO, Baenyi SP, Rono GK, et al
Whole-Genome Sequencing of SARS-CoV-2 Reveals Diverse Mutations in Circulating Alpha and Delta Variants during the First, Second and Third Waves of Covid-19 in South Kivu, East of the Democratic Republic of Congo.
Int J Infect Dis. 2022 May 19. pii: S1201-9712(22)00307.
PubMed Abstract available

KUDHAIL K, Thompson J, Mathews V, Morrison B, et al
Randomised controlled trials in COVID-19 patients: a systematic review and critical appraisal.
Int J Infect Dis. 2022 May 18. pii: S1201-9712(22)00299.
PubMed Abstract available

KIRSCH F, Lindemann AK, Geppert J, Borzekowski D, et al
Personal Protective Measures During the Coronavirus Pandemic in Germany.
Int J Infect Dis. 2022 May 18. pii: S1201-9712(22)00297.
PubMed Abstract available

EYU P, Elyanu P, Ario AR, Ntono V, et al
Investigation of Possible Preventable Causes of COVID-19 Deaths in the Kampala Metropolitan Area, Uganda, 2020-2021.
Int J Infect Dis. 2022 May 17. pii: S1201-9712(22)00296.
PubMed Abstract available

GUPTA S, Gupta T, Gupt N
Global Respiratory Virus Surveillance: Strengths, Gaps and Way Forward.
Int J Infect Dis. 2022 May 15. pii: S1201-9712(22)00294.
PubMed Abstract available

XUE L, Jing S, Zhang K, Milne R, et al
Infectivity versus fatality of SARS-CoV-2 mutations and influenza.
Int J Infect Dis. 2022 May 15. pii: S1201-9712(22)00295.
PubMed Abstract available

OKOTURO E, Amure M
SARS-CoV-2 saliva testing using reverse transcriptase - polymerase chain reaction (RT-PCR): A Systematic Review.
Int J Infect Dis. 2022 May 13. pii: S1201-9712(22)00272.
PubMed Abstract available

NISHIURA H, Jung SM, Hayashi K
High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children.
Int J Infect Dis. 2022 May 13. pii: S1201-9712(22)00290.
PubMed Abstract available

MARCO R, Angelo DV
Commentary to the paper: Association of smoking and severity of covid-19 infection among 5889 patients in malaysia: a multi-centre observational study, by Ismail N, Hassan N, Hamid MHNA, Yusoff UN, Khamal NR, Omar MA, et al. published in Int J Infect
Int J Infect Dis. 2022 May 12. pii: S1201-9712(22)00284.
PubMed

INGHELS M, Kane R, Lall P, Nelson D, et al
Ethnicity and risk of SARS-CoV-2 infection among the healthcare workforce: Results of a retrospective cohort study in rural United Kingdom.
Int J Infect Dis. 2022 May 12. pii: S1201-9712(22)00281.
PubMed Abstract available

YILDIZ Y, Ozger HS, Senol E, Karakus R, et al
Evaluation of long term antibody kinetics in healthcare workers (HCWs) vaccinated with inactivated COVID-19 vero cell vaccine (CoronaVac), a propensity score matched observational study: Antibody kinetics in HCWs after CoronaVac vaccination.
Int J Infect Dis. 2022 May 11. pii: S1201-9712(22)00271.
PubMed Abstract available

OLIVEIRA-SILVA J, Reis T, Lopes C, Batista-Silva R, et al
Long term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers.
Int J Infect Dis. 2022 May 11. pii: S1201-9712(22)00289.
PubMed Abstract available

CHEN F, Tian Y, Zhang L, Shi Y, et al
The Role of Children in Household Transmission of COVID-19: A Systematic Review and Meta-Analysis.
Int J Infect Dis. 2022 May 10. pii: S1201-9712(22)00283.
PubMed Abstract available

ICHIKAWA T, Torii S, Suzuki H, Takada A, et al
Mutations in the non-structural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in COVID-19 patients.
Int J Infect Dis. 2022 May 10. pii: S1201-9712(22)00275.
PubMed Abstract available

BALUSHI AA, Ajmi AA, Sinani QA, Menon V, et al
COVID-19 Associated Mucormycosis: Opportunistic Fugal Infection. A case series and review.
Int J Infect Dis. 2022 May 6. pii: S1201-9712(22)00267.
PubMed Abstract available

COLANERI M, Amarasinghe N, Rezzonico L, Pieri TC, et al
Early Remdesivir to prevent severe COVID-19 in solid organ transplant recipients: a real-life study from Northern Italy.
Int J Infect Dis. 2022 May 6. pii: S1201-9712(22)00263.
PubMed Abstract available

April 2022

KAMEGAI K, Iwamoto N, Togano T, Maeda K, et al
A Fatal Breakthrough Coronavirus Disease 2019 Case Following Bendamustine-Rituximab Therapy.
Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00258.
PubMed Abstract available

YOSHIMURA Y, Sasaki H, Miyata N, Miyazaki K, et al
An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.
Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00257.
PubMed Abstract available

HUSIN M, Tok PSK, Suah JL, Thevananthan T, et al
Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia.
Int J Infect Dis. 2022 Apr 29. pii: S1201-9712(22)00251.
PubMed Abstract available

BHAKTA S, Sanghavi DK, Johnson PW, Kunze KL, et al
Clinical and Laboratory Profiles of SARS-CoV-2 Delta Variant Compared to Pre-Delta Variants.
Int J Infect Dis. 2022 Apr 26. pii: S1201-9712(22)00252.
PubMed Abstract available

PAROLINA L, Pshenichnaya N, Vasilyeva I, Lizinfed I, et al
Clinical characteristics of COVID-19 in TB patients and factors associated with the disease severity.
Int J Infect Dis. 2022 Apr 25. pii: S1201-9712(22)00232.
PubMed Abstract available

LI J, Liu B, Tang X, Wu Z, et al
Development of a smartphone based quantum-dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies.
Int J Infect Dis. 2022 Apr 25. pii: S1201-9712(22)00235.
PubMed Abstract available

MURILLO-ZAMORA E, Trujillo X, Huerta M, Rios-Silva M, et al
COVID-19 vaccines provide better protection against related pneumonia than previous symptomatic infection.
Int J Infect Dis. 2022 Apr 24. pii: S1201-9712(22)00245.
PubMed Abstract available

XIA Y, Ma H, Buckeridge DL, Brisson M, et al
Mortality trends and lengths of stay among hospitalized COVID-19 patients in Ontario and Quebec (Canada): a population-based cohort study of the first three epidemic waves.
Int J Infect Dis. 2022 Apr 24. pii: S1201-9712(22)00246.
PubMed Abstract available

STEIN M, Cohen H, Nemet I, Atari N, et al
Human Metapneumovirus prevalence during 2019-2021 in Israel is influence by the COVID-19 pandemic.
Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00241.
PubMed Abstract available

TORRES JP, Saure D, Basso LJ, Zuniga M, et al
SARS-COV-2 IgG positivity in vaccinated and non-vaccinated Chilean children: a national cross-sectional study in Schools.
Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00238.
PubMed

LAI MY, Bukhari FDM, Zulkefli NZ, Ismail I, et al
Colorimetric detection of SARS-CoV-2 by uracil-DNA glycosylase (UDG) reverse transcription loop-mediated isothermal amplification (RT-LAMP).
Int J Infect Dis. 2022 Apr 23. pii: S1201-9712(22)00239.
PubMed Abstract available

MAMETJA S, Dessie ZG, Matoti L, Semenya M, et al
Clinical Management of COVID-19 in Hospitals and the Community: A Snapshot from a Medical Insurance Database in South Africa.
Int J Infect Dis. 2022 Apr 22. pii: S1201-9712(22)00231.
PubMed Abstract available

HUNG DT, Ghula S, Aziz JMA, Makram AM, et al
The efficacy and adverse effects of favipiravir on COVID-19 patients: a systematic review and meta-analysis of published clinical trials and observational studies.
Int J Infect Dis. 2022 Apr 22. pii: S1201-9712(22)00237.
PubMed Abstract available

PETRONE L, Picchianti-Diamanti A, Sebastiani GD, Aiello A, et al
Humoral and cellular responses to spike of delta SARS-CoV-2 variant in vaccinated patients with Immune Mediated Inflammatory Diseases.
Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00229.
PubMed Abstract available

LIU Y, Yu Y, Zhao Y, He D, et al
Reduction in the infection fatality rate of Omicron variant compared to previous variants in South Africa.
Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00228.
PubMed Abstract available

KOUTALOS AA, Stefanou N, Malizos KN
Post-acute sequelae of SARS-CoV-2 infection. Osteonecrosis must not be overlooked.
Int J Infect Dis. 2022 Apr 21. pii: S1201-9712(22)00226.
PubMed Abstract available

JAHAN N, Brahma A, Kumar MS, Bagepally BS, et al
Corrigendum to 'Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020-August 2021: a systematic review and meta-analysis' [International Journal of Infectious Diseases, Volume 116 (2022) P59-67].
Int J Infect Dis. 2022;119:119.
PubMed

VOO TC, Ballantyne A, Jenn NC, Cowling BJ, et al
Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.
Int J Infect Dis. 2022 Apr 14. pii: S1201-9712(22)00222.
PubMed Abstract available

TEGELER CM, Bilich T, Maringer Y, Salih HR, et al
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort.
Int J Infect Dis. 2022 Apr 14. pii: S1201-9712(22)00219.
PubMed Abstract available

RAMIREZ C, Duron RM
The Russia-Ukraine war could bring catastrophic public-health challenges beyond COVID-19.
Int J Infect Dis. 2022 Apr 12. pii: S1201-9712(22)00215.
PubMed

TEMBO J, Egbe NF, Maluzi K, Mulonga K, et al
Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia.
Int J Infect Dis. 2022 Apr 12. pii: S1201-9712(22)00216.
PubMed Abstract available

LIU K, Wang X, Song G
Association of epicardial adipose tissue with the severity and adverse clinical outcomes of COVID-19: A meta-analysis.
Int J Infect Dis. 2022 Apr 11. pii: S1201-9712(22)00212.
PubMed Abstract available

JABAL KA, Edelstein M
Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: Example from an Israeli Healthcare worker cohort.
Int J Infect Dis. 2022 Apr 9. pii: S1201-9712(22)00209.
PubMed Abstract available

WOLDAY D, de Wit TFR
Response to Abdelrahman M et al commentary on "Parasites Protect from Severe COVID-19. Myth or Reality?"
Int J Infect Dis. 2022 Apr 9. pii: S1201-9712(22)00211.
PubMed

SOMAN R, Chakraborty S, Joe G
Posaconazole or Isavuconazole as sole or predominant anti-fungal therapy for COVID-19 associated Mucormycosis. A retrospective observational case series.
Int J Infect Dis. 2022 Apr 8. pii: S1201-9712(22)00208.
PubMed

HAMBRIDGE HL, Kahn R, Onnela JP
Effect of a Two-Dose vs Three-Dose Vaccine Strategy in Residential Colleges Using an Empirical Proximity Network.
Int J Infect Dis. 2022 Apr 8. pii: S1201-9712(22)00206.
PubMed

DI LEGO V, Sanchez-Romero M, Prskawetz A
The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections.
Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00197.
PubMed Abstract available

HO LL, Gurung S, Mirza I, Nicolas HD, et al
Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00204.
PubMed Abstract available

WANG X, Wei J, Zhu R, Chen L, et al
Contribution of CD4+ T cell mediated inflammation to diarrhoea in patients with COVID-19.
Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00201.
PubMed Abstract available

MEDHAT R, El Lababidi R, Abdelsalam M, Nusair A, et al
Varicella Zoster Virus (VZV) Meningitis in an Immunocompetent Adult following BNT162b2 mRNA COVID-19 Vaccination: A Case Report.
Int J Infect Dis. 2022 Apr 6. pii: S1201-9712(22)00200.
PubMed Abstract available

March 2022

BURANASAKDA M, Kotruchin P, Phanthachai K, Mootsikapun P, et al
Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.
Int J Infect Dis. 2022 Mar 30. pii: S1201-9712(22)00192.
PubMed Abstract available

KLOPFENSTEIN T, Tipirdamaz C, Gendrin V, Osman M, et al
Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: the ANOSVID study.
Int J Infect Dis. 2022 Mar 29. pii: S1201-9712(22)00193.
PubMed

JEGERLEHNER S, Suter-Riniker F, Jent P, Bittel P, et al
Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting.
Int J Infect Dis. 2022 Mar 29. pii: S1201-9712(22)00176.
PubMed Abstract available

GHOSH A, Walia S, Rattan R, Kanampalliwar A, et al
Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India.
Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00181.
PubMed

ARKELL P, Gusmao C, Sheridan SL, Tanesi MY, et al
Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste.
Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00183.
PubMed Abstract available

JACKSON I, Jaradeh H, Aurit S, Aldamen A, et al
Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19.
Int J Infect Dis. 2022 Mar 28. pii: S1201-9712(22)00179.
PubMed Abstract available

ABU-ODAH H, Su JJ, Musa SS
Unwillingness or reluctance of Palestinians to get COVID-19 vaccine: the reasons behind it and how to persuade them.
Int J Infect Dis. 2022 Mar 25. pii: S1201-9712(22)00178.
PubMed Abstract available

CHANDA-KAPATA P, Ntoumi F, Kapata N, Lungu P, et al
Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa - A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic.
Int J Infect Dis. 2022 Mar 24. pii: S1201-9712(22)00173.
PubMed Abstract available

KIM AY, Woo W, Yon DK, Lee SW, et al
Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
Int J Infect Dis. 2022 Mar 23. pii: S1201-9712(22)00171.
PubMed Abstract available

LI R, Liu H, Fairley CK, Zou Z, et al
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States.
Int J Infect Dis. 2022 Mar 22. pii: S1201-9712(22)00168.
PubMed Abstract available

SUAH JL, Husin M, Keng PS, Hwa B, et al
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.
Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00167.
PubMed Abstract available

GUO Q, Wang J, Estill J, Lan H, et al
Risk of COVID-19 Transmission Aboard Aircraft: An Epidemiological Analysis Based on the National Health Information Platform.
Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00163.
PubMed Abstract available

MAKRAM AM, Alied M, Khan ZA, Huy NT, et al
Parasites Protect from Severe COVID-19. Myth or Reality?
Int J Infect Dis. 2022 Mar 21. pii: S1201-9712(22)00164.
PubMed

JEREMIAH C, Petersen E, Nantanda R, Mungai BN, et al
The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.
Int J Infect Dis. 2022 Mar 20. pii: S1201-9712(22)00149.
PubMed Abstract available

SHANAUBE K, Schaap A, Klinkenberg E, Floyd S, et al
SARS-CoV-2 seroprevalence and associated risk factors in peri-urban Zambia: a population-based study.
Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00158.
PubMed

INADA M, Ishikane M, Terada M, Matsunaga A, et al
Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection.
Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00155.
PubMed Abstract available

ONO A, Koizumi R, Tsuzuki S, Asai Y, et al
Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.
Int J Infect Dis. 2022 Mar 16. pii: S1201-9712(22)00157.
PubMed Abstract available

ELEC F, Magnusson J, Elec A, Muntean A, et al
COVID-19 AND KIDNEY TRANSPLANTATION: THE IMPACT OF REMDESIVIR ON RENAL FUNCTION AND OUTCOME- A RETROSPECTIVE COHORT STUDY.
Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00151.
PubMed Abstract available

NTOUMI F, Petersen E, Mwaba P, Aklillu E, et al
Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.: Invited viewpoint: IJID World TB Day series 2022.
Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00150.
PubMed Abstract available

O'KELLY B, Vidal L, Avramovic G, Broughan J, et al
Assessing the impact of COVID-19 at 1 year using the SF-12 questionnaire: Data from the Anticipate longitudinal cohort study.
Int J Infect Dis. 2022 Mar 14. pii: S1201-9712(22)00152.
PubMed Abstract available

MATTIUZZI C, Henry BM, Lippi G
COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
Int J Infect Dis. 2022 Mar 9. pii: S1201-9712(22)00146.
PubMed Abstract available

LEE DS, Kim JW, Lee KL, Jung YJ, et al
Adverse events following coronavirus disease 2019 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.
Int J Infect Dis. 2022 Mar 8. pii: S1201-9712(22)00145.
PubMed Abstract available

GLINERT I, Ben-Shmuel A, Szwartcwort-Cohen M, Beth-Din A, et al
Revisiting SARS-CoV-2 environmental contamination by COVID-19 patients: The Omicron variant does not differ from previous strains.
Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00139.
PubMed Abstract available

LIU ZG, Li XY
Interpretation of Discrepancies between Cities in the Transmission of COVID-19: Evidence from China in the First Weeks of the Pandemic: Interpreting the Discrepancies of COVID-19 Transmission.
Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00142.
PubMed Abstract available

MORENO-GARCIA E, Puerta-Alcalde P, Letona L, Meira F, et al
Bacterial co-infection at hospital admission in patients with COVID-19.
Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00143.
PubMed Abstract available

ADRIEN CSK, Alexandre C, Marie M, Cedric J, et al
Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients.
Int J Infect Dis. 2022 Mar 4. pii: S1201-9712(22)00141.
PubMed

RODRIGUEZ GD, Wu Y, Karnik K, Ruddy S, et al
Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at a NYC Hospital.
Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00137.
PubMed Abstract available

ASSAL HH, Abdelrahman S, Abdelbasset MA, Abdelaziz M, et al
Presepsin as a Novel Biomarker in predicting Inhospital Mortality in COVID-19 Pneumonia Patients.
Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00136.
PubMed Abstract available

PETERSEN E, Al-Abri S, Chakaya J, Goletti D, et al
World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic.
Int J Infect Dis. 2022 Mar 3. pii: S1201-9712(22)00138.
PubMed

MUSSO N, Maugeri JG, Bongiorno D, Stracquadanio S, et al
SARS-CoV-2's high rate of genetic mutation under immune selective pressure: from oropharyngeal B.1.1.7 to intrapulmonary B.1.533 in a post-vaccine patient.
Int J Infect Dis. 2022 Mar 2. pii: S1201-9712(22)00123.
PubMed Abstract available

LAYER E, Hoehl S, Ciesek S, Widera M, et al
SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach.
Int J Infect Dis. 2022 Mar 2. pii: S1201-9712(22)00121.
PubMed Abstract available

EFIMENKO I, Nackeeran S, Jabori S, Zamora JAG, et al
REMOVED: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database.
Int J Infect Dis. 2022;116S:S40.
PubMed Abstract available

February 2022

HUSSEY H, Davies MA, Heekes A, Williamson C, et al
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis.
Int J Infect Dis. 2022 Feb 27. pii: S1201-9712(22)00129.
PubMed Abstract available

SHURRAB FM, Younes N, Al-Sadeq DW, Liu N, et al
Performance evaluation of novel fluorescent-based lateral immune flow assay (LIFA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals.
Int J Infect Dis. 2022 Feb 26. pii: S1201-9712(22)00130.
PubMed Abstract available

ROUAMBA T, Ouedraogo E, Barry H, Yameogo NV, et al
Assessment of Recovery Time, Worsening and Death, among COVID-19 inpatients and outpatients, under treatment with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00111.
PubMed Abstract available

ALBAHRANI S, Ahmadi NA, Hamdan S, Elsheikh N, et al
Clinical Presentation and Outcome of hospitalized patients with COVID-19 in the first and second wave in Saudi Arabia.
Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00127.
PubMed Abstract available

THEOHARIDES TC, Guerra L, Patel K
Successful Treatment of a Severe COVID-19 Patient Using an Integrated Approach Addressing Mast Cells and Their Mediators.
Int J Infect Dis. 2022 Feb 25. pii: S1201-9712(22)00128.
PubMed Abstract available

HIRATA M, Fukuchi T, Sugawara H
Trajectory of SARS-CoV-2 anti-S IgG levels following transfusion and a third dose of BNT162b2 vaccine in a patient with massive postoperative bleeding: A case report.
Int J Infect Dis. 2022 Feb 24. pii: S1201-9712(22)00122.
PubMed Abstract available

XIE M, Dong N, Zhang X, He D, et al
Exported Cases were Infected on the Way: A Conjecture Derived from Analysis on Hong Kong Monthly Exported Covid-19 Cases.
Int J Infect Dis. 2022 Feb 23. pii: S1201-9712(22)00102.
PubMed

ROSENTHAL VD, Myatra SN, Divatia JV, Biswas S, et al
The impact of COVID-19 on healthcare-associated infections in intensive care units in low and middle income countries: International Nosocomial Infection Control Consortium (INICC) findings.
Int J Infect Dis. 2022 Feb 23. pii: S1201-9712(22)00120.
PubMed Abstract available

LITCHFIELD M, Brookes P, Ojrzynska A, Kavi J, et al
Comparison of the clinical sensitivity and specificity of two commercial RNA SARS-CoV-2 assays.
Int J Infect Dis. 2022 Feb 22. pii: S1201-9712(22)00109.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.